Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3000620	p-c3	g/l (g/l)	7550	12336	0.06%
3000620	s-c3	g/l (g/l)	5567	8607	0.00%
3000620	p-c3	— (—)	667	768	100.00%	Distribution not available
3000620	s-c3	— (—)	381	453	100.00%	Distribution not available
3000620	pf-c3	g/l (g/l)	120	135	0.00%
3000620	s-komplementtic3	g/l (g/l)	72	73	0.00%
3000620	pf-c3	— (—)	28	30	100.00%	Distribution not available
3000620	s-c3h	g/l (g/l)	7	7	0.00%	Distribution not available
3000620	pf-komplementtic3	g/l (g/l)	5	6	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Asthma, unspecified (mode)

1586

4077

3.03

322.70

1.6

1.21

1.17

g/l

6.65

1514

3887

Infections, IBD-co-morbidities

515

477

8.11

319.06

1.9

1.2

1.15

1.17

g/l

0.36

487

445

Care involving dialysis

478

702

7.80

317.21

2.0

1.5

1.06

1.19

g/l

13.15

455

654

Other joint disorders

2535

5571

2.46

316.90

1.8

1.7

1.17

g/l

0.12

2412

5303

ILD, hospital admission 2, with pulmonary infections

480

707

7.53

315.28

1.8

1.4

1.20

1.17

g/l

1.16

463

666

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1985

7086

2.59

314.06

1.8

1.6

1.18

g/l

0.37

1882

6728

Neurological diseases, wide definition

854

833

5.31

310.95

1.9

1.3

1.18

1.15

g/l

1.58

813

786

Pneumonias (Asthma/COPD co-morbidities)

3003

9406

2.20

310.50

1.9

1.6

1.19

1.17

g/l

1.86

2858

8964

Pneumonia, organism unspecified

2713

8566

2.28

308.88

1.8

1.6

1.19

1.17

g/l

1.56

2584

8159

All pneumoniae

3015

9440

2.19

308.16

1.9

1.6

1.19

1.17

g/l

1.93

2871

8994

Diseases of arteries, arterioles and capillaries

1983

5561

2.73

307.65

1.7

1.6

1.13

1.19

g/l

11.78

1895

5270

Seropositive rheumatoid arthritis

869

1915

4.78

307.65

2.0

1.2

1.14

1.19

g/l

4.46

833

1805

Rheumatoid arthritis

1230

2746

4.25

307.65

2.0

1.5

1.16

1.17

g/l

0.95

1176

2601

Finngen Rheumatological endpoints

3914

5730

4.07

307.65

2.4

1.2

1.16

1.19

g/l

4.54

3749

5429

Pain in joint

2293

4020

3.81

307.65

1.8

1.6

1.18

1.16

g/l

1.60

2182

3835

SLE, ICD10

809

343

59.27

307.65

6.7

1.3

1.02

1.20

g/l

19.58

785

324

Systemic sclerosis (FG)

283

148

27.27

307.65

2.2

1.1

1.08

1.20

g/l

4.02

271

135

Anaemias

1020

1200

5.90

307.65

2.3

1.8

1.15

1.11

g/l

2.42

976

1150

Headache

2040

5965

2.82

307.65

1.8

1.6

1.19

1.16

g/l

4.41

1934

5688

Other respiratory diseases principally affecting the interstitium

800

1603

5.44

307.65

1.8

1.5

1.19

1.17

g/l

0.92

773

1517

Bacterial Sepsis

1609

4020

3.59

307.65

1.9

1.5

1.15

1.18

g/l

3.03

1516

3806

Acute renal failure

1004

1780

6.16

307.65

1.9

1.5

1.15

1.17

g/l

1.44

957

1679

Abnormalities of breathing

2858

6667

2.56

307.65

1.8

1.6

1.20

1.17

g/l

6.63

2723

6360

Oedema, not elsewhere classified

1271

2871

4.64

307.65

1.7

1.5

1.20

1.16

g/l

3.44

1191

2719

Azathioprine

812

1228

7.33

307.65

3.9

1.4

1.12

1.17

g/l

3.63

788

1170

Autoimmune diseases excluding thyroid diseases, strict definition

4336

5877

4.25

307.65

2.3

1.2

1.14

1.19

g/l

16.47

4156

5581

Asthma, unspecified (mode), excluding more controls

1561

3826

3.16

307.65

1.6

1.21

1.17

g/l

6.44

1492

3646

Dyspnoea

2772

8954

2.36

307.65

1.8

1.7

1.19

1.17

g/l

3.30

2642

8518

L04AA Selective immunosuppressants

1237

2676

5.11

307.65

3.4

1.5

1.11

1.20

g/l

14.85

1199

2536

Systemic lupus erythematosus, unspecified

738

301

68.13

307.65

6.7

1.3

1.02

1.21

g/l

20.77

715

286

SLE, strict definition

809

343

59.27

307.65

6.7

1.3

1.02

1.20

g/l

19.58

785

324

Systemic sclerosis

283

196

20.49

307.65

2.2

1.1

1.08

1.23

g/l

7.77

271

183

Implicit Sepsis

2386

6813

2.74

307.65

1.8

1.6

1.16

1.18

g/l

2.61

2257

6491

Fever of other and unknown origin

2379

5160

4.34

307.65

2.1

1.6

1.21

1.16

g/l

7.36

2269

4913

ILD, hospital admissions

693

1320

5.77

307.65

1.8

1.5

1.19

1.16

g/l

1.16

671

1244

Other bacterial diseases

2993

8163

2.54

307.65

1.8

1.6

1.20

1.17

g/l

3.06

2846

7777

Dermatitis and eczema

3533

9408

2.40

307.65

1.8

1.7

1.17

g/l

0.08

3377

8939

All chronic kidney diseases

2554

4512

4.97

307.65

2.1

1.6

1.17

g/l

0.44

2445

4268

Oral corticosteroids

5012

6629

4.76

307.65

2.1

1.3

1.19

1.17

g/l

2.80

4765

6301

Condition for Implicit Sepsis (Organ dysfunction codes)

2551

7683

2.41

307.65

1.8

1.6

1.16

1.18

g/l

3.20

2418

7320

ILD, hospital admissions 1, main diag only

643

1178

6.03

307.65

1.8

1.4

1.19

1.16

g/l

1.48

624

1109

Other specified/unspecified arthritis

1210

2592

5.02

307.65

1.8

1.6

1.18

1.17

g/l

0.43

1167

2458

Interstitial lung disease

696

1332

5.73

307.65

1.8

1.5

1.19

1.16

g/l

1.13

674

1255

Other necrotizing vasculopathies (FG)

444

382

13.98

307.65

2.1

1.2

1.23

1.18

g/l

1.23

424

357

2780

6918

2.51

307.65

1.9

1.6

1.19

1.16

g/l

3.63

2650

6596

Other and unspecified vasculitis limited to skin

326

199

25.09

307.65

1.8

1.5

1.22

1.18

g/l

0.95

314

190

Implicit Sepsis

2526

7477

2.55

307.65

1.8

1.6

1.16

1.18

g/l

2.79

2392

7127

First line medication for Crohn's disease

4701

6132

4.35

307.65

2.1

1.3

1.18

1.17

g/l

0.83

4475

5836

Second line medication for Crohn's disease

2905

7155

4.37

307.65

2.5

1.5

1.16

1.18

g/l

4.18

2799

6793

Other peripheral vascular diseases

633

766

9.89

307.65

1.8

1.7

1.05

1.18

g/l

19.83

614

722

Other interstitial pulmonary diseases

696

1321

5.78

307.65

1.8

1.4

1.19

1.16

g/l

1.14

674

1245

Interstitial lung disease endpoints

696

1332

5.73

307.65

1.8

1.5

1.19

1.16

g/l

1.13

674

1255

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

3816

8523

3.23

307.65

1.9

1.6

1.16

1.18

g/l

4.30

3623

8120

Asthma (only as main-diagnosis), excluding more controls

2207

4122

3.17

307.65

1.6

1.21

1.17

g/l

9.39

2098

3933

Arthropathies

2713

5594

2.52

307.65

1.8

1.7

1.18

1.17

g/l

0.79

2593

5326

Systemic connective tissue disorders

3497

3313

12.96

307.65

3.0

1.2

1.13

1.20

g/l

19.53

3379

3110

Glomerular disorders in diseases classified elsewhere

823

1021

9.48

307.65

3.3

1.4

1.15

1.18

g/l

2.04

783

960

Autoimmune diseases

3828

6109

3.30

307.65

2.1

1.2

1.16

1.19

g/l

7.84

3659

5799

Influenza and pneumonia

3172

9402

2.20

307.65

1.9

1.6

1.19

1.17

g/l

2.23

3018

8962

Asthma

2385

4396

2.93

307.65

1.6

1.21

1.17

g/l

10.35

2276

4196

Asthma (only as main-diagnosis)

2239

4396

3.04

307.65

1.6

1.21

1.17

g/l

9.85

2129

4196

Systemic lupus erythematosus

824

301

65.64

307.65

6.6

1.2

1.03

1.22

g/l

19.27

800

282

Autoimmune diseases excluding thyroid diseases

4476

6062

4.24

307.65

2.3

1.2

1.14

1.19

g/l

16.51

4285

5755

Nephropathy related operations

670

1174

6.42

307.65

1.9

1.4

1.08

1.19

g/l

11.29

634

1106

Dialysis, with operation codes

715

1095

7.38

307.65

1.9

1.5

1.08

1.18

g/l

10.98

676

1031

Bacterial infection, other or unspecified

1798

4869

3.35

307.65

1.8

1.5

1.20

1.17

g/l

2.14

1694

4621

Adverse effects, not elsewhere classified

1064

2465

4.74

307.65

1.7

1.8

1.20

1.18

g/l

1.60

973

2350

Other specific joint derangements/joint disorders

2710

5464

3.34

307.65

1.8

1.7

1.18

1.17

g/l

0.97

2582

5203

General symptoms and signs

3542

6354

2.88

307.65

1.8

1.6

1.19

1.16

g/l

4.40

3372

6058

Rheumatoid arthritis, including avohilmo

1404

4520

3.27

307.65

2.0

1.6

1.16

1.19

g/l

2.66

1342

4263

Autoimmune diseases related-to ILD

3941

8476

4.22

307.65

2.6

1.3

1.16

1.18

g/l

4.91

3788

8025

Glomerulonephritis

634

945

7.73

307.65

2.7

1.5

1.16

1.17

g/l

0.56

606

888

Other systemic involvement of connective tissue (FG)

2410

1998

14.38

307.65

2.6

1.2

1.14

1.19

g/l

8.78

2337

1883

Chronic kidney disease

1608

2438

7.13

307.65

1.8

1.5

1.14

1.17

g/l

2.42

1534

2291

Other bacterial diseases

3165

8523

2.43

307.65

1.8

1.6

1.20

1.17

g/l

4.37

3017

8124

Polyarthropathies

2799

4826

3.99

307.65

1.8

1.6

1.19

1.17

g/l

1.90

2679

4587

Asthma (mode)

2347

4448

2.91

307.65

1.6

1.22

1.17

g/l

11.02

2233

4246

Renal failure

2157

3678

5.61

307.65

1.8

1.5

1.15

1.18

g/l

2.50

2059

3457

Used for control exclusion in common control thyroid runs

3470

5653

3.21

307.65

2.1

1.2

1.16

1.19

g/l

6.81

3321

5366

Renal tubulo-interstitial diseases

3081

8310

2.87

307.65

1.9

1.6

1.18

g/l

0.08

2948

7899

Mixed connective tissue disease

1024

650

25.69

307.65

3.5

1.5

1.08

1.20

g/l

14.65

998

613

Other necrotizing vasculopathies

535

529

12.22

307.65

2.6

1.2

1.22

1.21

g/l

0.16

511

497

Dermatitis

2262

7607

3.10

307.65

1.8

1.6

1.18

g/l

0.01

2166

7226

Urticaria

1352

3885

3.72

307.65

1.8

1.7

1.18

1.17

g/l

0.44

1270

3709

Other soft tissue disorders, not elsewhere classified

3061

7123

2.60

307.65

1.8

1.7

1.19

1.16

g/l

6.13

2915

6780

Implicit bacterial Sepsis

1411

3532

3.72

307.65

1.9

1.5

1.15

1.18

g/l

1.92

1325

3337

Glomerular diseases

1252

1809

8.00

307.65

2.9

1.5

1.15

1.18

g/l

2.36

1196

1706

Other systemic involvement of connective tissue

2455

2550

11.59

307.65

2.6

1.2

1.14

1.20

g/l

13.39

2381

2388

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2780

6918

2.51

307.65

1.9

1.6

1.19

1.16

g/l

3.63

2650

6596

L04AX Other immunosuppressants

2851

6937

4.43

307.65

2.5

1.5

1.16

1.18

g/l

4.11

2747

6584

Other and unspecified effects of external causes

1218

3568

3.64

307.65

1.7

1.8

1.19

1.17

g/l

1.45

1121

3420

Implicit bacterial Sepsis

1517

3827

3.59

307.65

1.9

1.5

1.16

1.18

g/l

1.60

1428

3622

Cardiovascular diseases

2010

3798

2.94

307.65

2.0

1.7

1.17

1.15

g/l

1.83

1933

3616

Heart failure, not strict

2392

5718

2.95

307.65

1.9

1.6

1.18

1.19

g/l

0.40

2283

5440

Vasculitis limited to skin, not elsewhere classified

343

224

22.80

307.65

1.8

1.5

1.22

1.18

g/l

1.02

331

214

Urticaria and erythema

1628

4786

3.63

307.65

1.9

1.7

1.18

g/l

0.39

1535

4565

Diseases of the skin and subcutaneous tissue

2940

5818

2.60

307.65

1.8

1.6

1.18

1.17

g/l

0.20

2794

5543

Other arthritis (FG)

1366

2628

5.58

307.65

1.8

1.2

1.18

1.19

g/l

0.12

1316

2488

Bacterial infection, other or unspecified

1916

5303

3.19

307.65

1.8

1.6

1.20

1.17

g/l

2.56

1807

5042

SLE (Finngen)

824

212

93.80

307.65

6.6

1.1

1.03

1.26

g/l

16.98

800

200

Certain disorders involving the immune mechanism

928

2176

4.66

307.65

1.9

1.6

1.19

g/l

0.32

880

2071

Reimbursement for rheumatic diseases

3273

6589

5.41

307.65

2.8

1.3

1.14

1.19

g/l

12.96

3157

6244

Other and unspecified dermatitis

2028

6331

3.37

307.65

1.8

1.6

1.18

g/l

0.03

1944

6023

All kidney diseases

3559

8758

2.89

307.65

2.0

1.6

1.18

1.17

g/l

0.97

3411

8316

Cutaneous lupus erythematosus

381

216

29.67

307.65

3.9

1.5

1.08

1.20

g/l

6.07

374

204

Raynaud syndrome

709

954

8.99

307.65

1.8

1.05

1.19

g/l

24.14

687

894

Other disorders of skin and subcutaneous tissue

2443

7589

2.98

307.65

2.1

1.6

1.17

1.18

g/l

1.06

2323

7208

Asthma, excluding more controls

2338

4122

3.05

307.65

1.6

1.22

1.17

g/l

9.78

2231

3933

Pain in limb

2479

6922

2.47

307.65

1.8

1.7

1.20

1.16

g/l

6.38

2362

6586

Sicca syndrome [Sjögren]

1033

732

19.62

307.65

2.6

1.2

1.13

1.22

g/l

12.37

1012

696

Other specified/unspecified systemic involvement of connective tissue

895

466

30.58

307.65

3.4

1.2

1.08

1.22

g/l

15.66

872

438

ILD medications

5207

5999

4.98

307.65

2.1

1.3

1.18

1.17

g/l

0.46

4971

5691

Inflammatory bowel disease treatment related agents

5137

6890

4.40

307.65

2.1

1.4

1.18

1.17

g/l

2.62

4893

6552

ILD medications: immunosuppressive drugs

3640

5373

6.86

307.65

2.6

1.3

1.15

1.17

g/l

3.67

3502

5095

ILD medications: azathioprine

812

1084

8.32

307.65

3.9

1.3

1.12

1.18

g/l

4.84

788

1030

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

653

282

18.39

307.65

1.8

1.2

1.19

1.18

g/l

0.41

632

259

ILD medications: prednisolone, methylprednisolone, prednisone

5039

5879

5.08

307.65

2.2

1.3

1.18

1.17

g/l

0.39

4805

5575

Cardiovascular diseases (excluding rheumatic etc)

2058

4590

2.66

306.47

2.1

1.7

1.19

1.14

g/l

9.34

1974

4377

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

456

663

7.83

304.98

1.9

1.4

1.30

1.17

g/l

9.66

429

635

Examination and observation for other reasons

1798

3773

2.84

303.69

1.7

1.5

1.18

g/l

0.57

1716

3617

Coagulation defects, purpura and other haemorrhagic conditions

866

2217

4.21

302.91

2.5

1.7

1.13

1.18

g/l

3.84

819

2099

Septicaemia

1278

3873

3.21

302.15

1.9

1.5

1.16

g/l

0.15

1210

3667

Diseases of the musculoskeletal system and connective tissue

1473

2311

3.28

300.70

2.0

1.2

1.16

1.18

g/l

1.50

1410

2199

Other and unspecified urticaria

901

2390

4.06

299.82

1.8

1.17

1.18

g/l

0.60

840

2274

Unspecified kidney failure

462

689

7.37

299.44

1.6

1.4

1.15

1.16

g/l

0.48

441

649

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2919

9373

2.18

296.11

1.9

1.6

1.19

1.17

g/l

1.82

2773

8934

Tramadol

2352

6141

2.42

295.48

1.8

1.6

1.22

1.16

g/l

15.08

2238

5843

Implicit viral Sepsis

1014

2939

3.63

293.11

2.1

1.6

1.14

1.18

g/l

2.64

953

2787

Condition for Implicit Sepsis (Organ dysfunction codes)

2602

8144

2.26

289.42

1.8

1.6

1.16

1.18

g/l

3.30

2470

7769

Explicit Sepsis

1357

4359

3.02

288.94

1.9

1.5

1.16

1.18

g/l

0.80

1288

4134

Asthma, hospital admission 2, infections

1872

7468

2.54

288.68

1.7

1.22

1.16

g/l

12.34

1779

7102

Asthma-related infections

1872

7468

2.54

288.68

1.7

1.22

1.16

g/l

12.34

1779

7102

Hypertensive diseases (excluding secondary)

1641

3389

2.91

288.32

2.0

1.6

1.22

1.15

g/l

15.78

1575

3219

Systemic sclerosis, icd10

283

250

16.07

287.09

2.2

1.6

1.08

1.20

g/l

6.09

271

237

Malaise and fatigue

1447

4121

2.92

281.28

1.7

1.5

1.19

1.16

g/l

1.94

1367

3910

Other heart diseases

1500

3456

2.93

276.93

1.9

1.6

1.19

1.15

g/l

4.48

1432

3295

Other septicaemia

1132

3474

3.26

276.54

1.8

1.5

1.16

g/l

0.08

1076

3285

Immunodeficiencies

372

489

9.24

275.42

2.1

1.6

1.18

1.20

g/l

0.46

345

460

Certain infectious and parasitic diseases

2731

6249

2.24

273.70

1.9

1.6

1.18

1.17

g/l

0.84

2599

5968

Aplastic and other anaemias

1373

4579

2.90

272.13

1.8

1.5

1.13

1.18

g/l

6.18

1297

4329

Abnormal findings on diagnostic imaging of lung

1420

4980

2.84

271.51

1.7

1.5

1.17

1.18

g/l

0.53

1343

4718

Any reimbursement code in KELA

1692

3096

2.81

268.67

2.0

1.3

1.18

1.15

g/l

2.70

1611

2950

Other pulmonary diagnosis

2130

4446

2.46

261.85

1.8

1.6

1.19

1.17

g/l

3.21

2034

4246

Other diseases of pleura

1308

4073

2.92

258.93

2.0

1.5

1.13

1.18

g/l

5.54

1242

3843

Heart failure and antihypertensive medication

783

1220

4.40

258.54

1.8

1.5

1.17

1.15

g/l

1.00

751

1159

Viral Sepsis

745

1926

4.11

255.54

2.2

1.5

1.15

1.18

g/l

1.76

697

1825

GASTRO-related operations

2207

4746

2.38

255.28

1.8

1.6

1.19

1.16

g/l

3.24

2090

4562

Any gastric operation

2207

4746

2.38

255.28

1.8

1.6

1.19

1.16

g/l

3.24

2090

4562

Implicit viral Sepsis

743

1923

4.10

254.45

2.2

1.5

1.15

1.18

g/l

1.74

695

1822

Excluding asthma or asthma-COPD overlap

2110

4446

2.43

254.28

1.8

1.6

1.19

1.17

g/l

3.53

2014

4246

1466

5626

2.68

253.20

1.7

1.22

1.16

g/l

11.74

1394

5343

Other and unspecified anaemias

1253

4243

2.92

252.89

1.8

1.5

1.13

1.18

g/l

4.82

1188

4011

Other anaemias

1259

4284

2.90

250.47

1.8

1.5

1.13

1.18

g/l

4.98

1194

4051

Antihypertensive medication - note that there are other indications

1848

3936

2.56

249.88

2.1

1.7

1.18

1.14

g/l

7.73

1772

3751

ILD differential diagnosis

2093

4448

2.41

247.67

1.8

1.6

1.19

1.17

g/l

3.13

1997

4246

COPD differential diagnosis

2093

4450

2.41

247.45

1.8

1.6

1.19

1.17

g/l

3.16

1997

4248

Fibromyalgia

494

955

5.73

246.70

1.9

1.8

1.23

1.18

g/l

3.13

468

900

Ulcer of lower limb, not elsewhere classified

549

1160

5.09

245.29

1.8

1.4

1.19

1.18

g/l

0.26

519

1095

Asthma (diagnoses ohter than nonallergic)

2532

10242

2.10

244.71

1.6

1.7

1.22

1.16

g/l

14.95

2407

9745

Symptoms and signs involving the circulatory and respiratory systems

2772

6686

2.12

244.45

1.9

1.6

1.19

1.17

g/l

2.86

2644

6378

L04AD Calcineurin inhibitors

559

1215

5.10

243.87

2.7

1.6

1.11

1.19

g/l

6.44

531

1147

Abnormal findings on examination of blood, without diagnosis

1376

4800

2.73

242.26

1.8

1.6

1.22

1.17

g/l

7.12

1302

4556

Pain in throat and chest

2317

6402

2.22

240.60

1.8

1.6

1.19

1.17

g/l

2.54

2212

6103

Secondary hypertension

367

537

7.39

237.97

2.8

1.5

1.13

1.17

g/l

1.22

347

508

ILD, hospital admissions 3, with pneumonia sepsis

391

624

6.92

237.97

1.8

1.4

1.20

1.16

g/l

1.56

379

588

Heart failure,strict

1369

3573

2.79

237.21

1.7

1.5

1.15

1.18

g/l

2.62

1304

3390

Nephrotic syndrome

270

288

11.83

237.00

2.3

1.3

1.17

1.20

g/l

0.52

260

270

Extracorporeal dialysis

362

550

7.60

233.42

2.0

1.4

1.05

1.18

g/l

10.32

342

522

Other disorders of lacrimal gland

1183

4308

2.87

231.71

2.3

1.6

1.16

1.18

g/l

2.16

1137

4068

Opioids

2695

6862

2.08

229.25

1.8

1.7

1.20

1.15

g/l

10.77

2555

6537

COPD/asthma related infections

2790

6919

2.06

228.72

1.9

1.6

1.19

1.16

g/l

4.03

2659

6597

COPD/asthma/ILD related infections

2790

6919

2.06

228.72

1.9

1.6

1.19

1.16

g/l

4.03

2659

6597

Hypothyroidism, strict autoimmune

1755

4898

2.41

224.54

1.8

1.2

1.19

g/l

0.20

1658

4644

Pain, not elsewhere classified

867

2694

3.35

223.72

1.8

1.6

1.19

1.16

g/l

2.38

832

2559

Codeine

2555

6770

2.09

223.20

1.8

1.7

1.21

1.16

g/l

13.47

2413

6448

Other heart diseases, wide

2600

7916

2.05

221.97

1.8

1.7

1.19

1.18

g/l

0.48

2484

7544

Cerebrovascular diseases (FINNGEN)

918

1988

3.39

220.09

1.9

1.6

1.21

1.16

g/l

4.48

882

1887

Medical observation and evaluation for suspected diseases and conditions

1774

3785

2.45

219.10

1.9

1.5

1.18

g/l

0.59

1705

3627

Purpura and other haemorrhagic conditions

581

1416

4.44

217.64

2.5

1.6

1.13

1.18

g/l

2.56

545

1334

Gout

744

1843

3.70

216.25

1.4

1.5

1.23

1.17

g/l

4.77

708

1743

Symptoms and signs involving the skin and subcutaneous tissue

2045

9563

2.15

215.67

1.8

1.7

1.16

1.18

g/l

1.26

1956

9086

Asthma, hospital admissions , main diagnosis only

2336

10307

2.05

213.15

1.6

1.7

1.21

1.16

g/l

10.95

2219

9805

Disorders of thyroid, IBD co-morbidities

462

584

5.76

212.82

1.8

1.2

1.19

1.15

g/l

1.38

433

549

Diseases of arteries, arterioles and capillaries (FINNGEN)

710

1286

3.98

212.05

1.6

1.5

1.18

1.16

g/l

1.07

671

1219

Sulfasalazine

814

2516

3.36

211.66

1.5

1.4

1.18

1.17

g/l

0.38

768

2394

Polymyalgia rheumatica

459

944

5.21

211.48

1.6

1.2

1.23

1.19

g/l

1.52

438

878

Polyneuropathies and other disorders of the peripheral nervous system

752

2226

3.58

211.36

1.8

1.5

1.14

1.18

g/l

2.85

714

2103

Soft tissue disorders

2747

7200

2.00

210.47

1.8

1.7

1.19

1.16

g/l

3.09

2615

6854

Asthma-related pneumonia

1087

3977

2.83

209.12

1.7

1.6

1.21

1.16

g/l

5.38

1037

3751

Asthma-related pneumonia or sepsis

1088

3988

2.83

208.55

1.7

1.6

1.21

1.16

g/l

5.37

1038

3761

Asthma, hospital admissions 3, pneumonia

1088

3988

2.83

208.55

1.7

1.6

1.21

1.16

g/l

5.37

1038

3761

Other and unspecified polyneuropathies, also in other diseases

676

1888

3.81

207.90

1.8

1.5

1.14

1.18

g/l

2.87

645

1784

Other disorders involving the immune mechanism, not elsewhere classified

257

305

10.46

207.64

1.9

1.4

1.19

1.20

g/l

0.13

244

290

Hypertension, essential

2084

5542

2.18

202.82

1.8

1.6

1.24

1.16

g/l

27.28

1990

5288

Enlarged lymph nodes

554

1366

4.29

202.53

2.6

1.6

1.17

g/l

0.24

539

1288

Disorders of lacrimal system

1320

5418

2.52

200.85

2.2

1.6

1.16

1.18

g/l

1.90

1269

5130

Parasetamol

1970

4552

2.24

198.87

1.8

1.7

1.19

1.14

g/l

10.15

1879

4329

Chronic lower respiratory diseases

3227

9447

1.85

198.79

1.6

1.7

1.20

1.16

g/l

9.29

3072

8991

Erysipelas

1810

6373

2.22

198.24

1.7

1.6

1.20

1.17

g/l

3.33

1715

6060

2999

8314

1.90

197.54

1.8

1.6

1.19

1.16

g/l

5.15

2852

7922

Hypertensive diseases

2130

5777

2.13

195.76

2.0

1.6

1.23

1.16

g/l

19.49

2037

5514

Dorsalgia

2664

7410

1.96

195.20

1.7

1.19

1.17

g/l

3.50

2530

7074

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

241

286

10.48

194.83

1.9

1.5

1.19

1.20

g/l

0.07

228

272

Pleural effusion

531

1311

4.31

194.29

2.1

1.4

1.05

1.18

g/l

10.26

505

1242

Hypertension

2122

5774

2.12

193.30

2.0

1.6

1.23

1.16

g/l

19.48

2030

5511

Heart failure, strict

1441

4325

2.42

187.65

1.7

1.5

1.15

1.19

g/l

3.40

1373

4093

Diseases of oesophagus, stomach and duodenum

2812

9104

1.88

187.13

1.8

1.6

1.18

g/l

0.04

2652

8690

Other diseases of pericardium

243

301

9.17

186.61

2.5

1.4

1.19

g/l

0.10

229

280

Immunodeficiency with predominantly antibody defects

234

285

10.42

186.02

2.1

1.6

1.16

1.20

g/l

0.69

221

268

Bronchitis

2861

9865

1.86

185.92

1.9

1.7

1.19

1.17

g/l

4.14

2714

9398

Asthma, including avohilmo

3118

9767

1.83

185.79

1.6

1.7

1.21

1.16

g/l

12.85

2965

9296

Polyarthrosis

617

1605

3.74

184.07

1.6

1.4

1.19

1.18

g/l

0.04

593

1517

Erysipelas

1379

5265

2.38

182.79

1.7

1.5

1.20

1.18

g/l

2.07

1298

5006

Dental caries

812

2622

3.10

182.26

1.9

1.6

1.16

1.18

g/l

1.13

778

2479

Codeine or tramadol medication

2980

9012

1.84

181.77

1.7

1.21

1.16

g/l

12.73

2818

8583

Seropositive rheumatoid arthritis, wide

868

3069

2.96

179.96

2.0

1.6

1.14

1.19

g/l

4.92

832

2896

All-cause Heart Failure

1404

4253

2.40

179.50

1.7

1.5

1.15

1.19

g/l

3.49

1340

4023

Methotrexate

469

1119

4.43

179.21

2.3

1.3

1.15

1.18

g/l

0.80

452

1063

Migraine

1532

5640

2.27

177.62

1.9

1.8

1.18

1.16

g/l

1.82

1453

5383

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

870

1370

3.25

176.69

1.7

1.5

1.18

1.16

g/l

0.61

822

1317

Low back pain

2011

7235

2.04

175.06

1.7

1.21

1.17

g/l

6.78

1906

6906

Gout, FINNGEN

744

2438

3.16

174.59

1.4

1.23

1.16

g/l

6.00

708

2296

CR(E)ST syndrome

174

160

15.25

171.84

2.0

1.6

1.07

1.21

g/l

5.70

164

153

Other/unspecified seropositive rheumatoid arthritis

849

3045

2.92

171.40

2.0

1.6

1.14

1.19

g/l

4.70

814

2872

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

839

3021

2.91

168.20

2.0

1.6

1.14

1.19

g/l

4.42

804

2849

Cough

1116

4335

2.51

168.05

1.8

1.6

1.19

1.17

g/l

0.88

1068

4124

Caries of dentine

724

2340

3.14

166.30

1.9

1.5

1.16

1.18

g/l

0.95

693

2213

Chronic nephritic syndrome

239

336

8.26

165.67

3.0

1.4

1.12

1.21

g/l

3.78

231

317

Neurological diseases

2219

5759

1.97

162.16

1.7

1.19

1.16

g/l

6.54

2112

5487

Osteopathies and chondropathies

1527

6776

2.16

161.19

2.0

1.6

1.17

1.18

g/l

0.42

1463

6431

Persons encountering health services for specific procedures and health care

2814

9590

1.79

160.03

1.8

1.7

1.17

1.18

g/l

0.47

2680

9131

Hypothyroidism (congenital or acquired)

719

1243

3.36

159.39

2.0

1.8

1.19

1.11

g/l

7.05

678

1189

Acute upper respiratory infections

2675

9258

1.81

159.11

1.8

1.7

1.20

1.17

g/l

5.81

2544

8817

Episodal and paroxysmal disorders

2813

8058

1.81

158.68

1.7

1.21

1.15

g/l

14.42

2680

7680

Certain infectious and parasitic diseases

1812

4382

2.11

158.54

1.8

1.5

1.19

1.17

g/l

1.01

1723

4180

Seronegative rheumatoid arthritis

368

813

4.79

155.21

1.8

1.2

1.16

1.19

g/l

0.91

351

764

Lower back pain or/and sciatica

2712

10115

1.78

154.68

1.7

1.20

1.17

g/l

8.10

2572

9631

Metabolic disorders

2404

8042

1.86

154.60

1.6

1.7

1.20

1.17

g/l

5.25

2277

7673

Hard cardiovascular diseases

2085

6505

1.95

154.05

1.7

1.6

1.20

1.18

g/l

2.41

1986

6189

Hypothyroidism and >3 levothyroxin purchases

707

1239

3.32

153.80

2.0

1.8

1.19

1.11

g/l

8.15

668

1185

Hypothyroidism, levothyroxine purchases

707

1239

3.32

153.80

2.0

1.8

1.19

1.11

g/l

8.15

668

1185

Other diseases of intestines

2753

8914

1.79

153.79

1.7

1.19

1.17

g/l

1.70

2625

8489

Myalgia

740

2616

2.95

153.05

1.8

1.7

1.19

1.17

g/l

0.84

705

2488

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1180

3138

2.44

152.56

2.0

1.6

1.19

1.15

g/l

4.38

1127

2976

Acute upper respiratory infections of multiple and unspecified sites

2013

7866

1.94

152.49

1.9

1.7

1.20

1.17

g/l

4.53

1909

7492

Complications of surgical and medical care, not elsewhere classified

2539

9827

1.80

151.63

1.8

1.7

1.18

1.17

g/l

0.77

2398

9359

Other dorsopathies, not elsewhere classified

2556

7447

1.83

150.58

1.7

1.19

1.17

g/l

2.26

2419

7109

Viral infections characterized by skin and mucous membrane lesions

2259

10703

1.84

150.26

2.1

1.6

1.15

1.18

g/l

3.44

2158

10181

Other special examinations and investigations of persons without complaint or reported diagnosis

1593

3785

2.17

150.20

1.8

1.5

1.17

1.18

g/l

1.21

1511

3627

Pain (limb, back, neck, head abdominally)

1708

4148

2.10

147.85

1.7

1.6

1.19

1.16

g/l

3.41

1624

3956

Disorders of eyelid, lacrimal system and orbit

2202

9185

1.86

147.63

2.0

1.6

1.17

1.18

g/l

0.45

2106

8730

Complications of medical and surgical care

1921

9396

1.92

147.63

1.8

1.7

1.19

1.17

g/l

1.32

1806

8955

General examination and investigation of persons without complaint and reported diagnosis

1542

3784

2.17

146.02

1.8

1.5

1.17

1.18

g/l

1.02

1471

3626

Intestinal infectious diseases

2425

10460

1.79

144.82

1.8

1.7

1.18

1.17

g/l

0.08

2297

9962

Codes for special purposes

1455

7115

2.10

144.47

1.9

1.7

1.19

1.17

g/l

1.69

1394

6772

Other (seronegative) rheumatoid arthritis, wide

625

2095

3.14

143.07

1.9

1.6

1.16

1.19

g/l

1.72

591

1969

Provisional assignment of new diseases of uncertain etiology

1450

7107

2.09

143.07

1.9

1.7

1.19

1.17

g/l

1.57

1390

6763

Cardiac arrhythmias

1600

5120

2.08

143.04

1.8

1.7

1.20

1.14

g/l

8.89

1527

4877

Persons encountering health services in other circumstances, wide

2912

8805

1.73

142.45

1.8

1.6

1.18

1.17

g/l

0.08

2789

8352

Obesity related asthma

981

4133

2.46

141.89

1.5

1.7

1.30

1.17

g/l

35.89

935

3915

Diarrhoea and gastroenteritis of presumed infectious origin

1862

8937

1.92

141.68

1.8

1.7

1.18

1.17

g/l

0.25

1771

8511

IgA nephropathy (IgA glomerulonephritis)

184

232

9.72

141.46

1.5

1.19

1.17

g/l

0.18

173

222

Giant cell arteritis

202

280

8.14

140.98

1.7

1.2

1.31

1.20

g/l

3.24

190

262

Other abnormal immunological findings in serum

178

221

10.12

139.20

1.9

1.5

1.16

1.19

g/l

0.67

167

209

Symptoms and signs involving the nervous and musculoskeletal systems

1534

7763

2.02

138.86

1.8

1.6

1.17

1.18

g/l

0.48

1470

7372

Haemorrhage from respiratory passages

828

2899

2.65

138.60

1.8

1.5

1.18

g/l

0.08

781

2745

Nerve, nerve root and plexus disorders

2637

9425

1.74

137.63

1.6

1.7

1.20

1.17

g/l

3.69

2505

8963

Transplanted organ and tissue status

386

978

4.25

137.25

1.8

1.5

1.09

1.20

g/l

7.20

366

925

Covid-19 confirmed case

1003

4348

2.38

135.75

1.9

1.6

1.18

1.17

g/l

0.79

959

4119

Nutritional anaemias

1269

5812

2.16

135.69

1.8

1.6

1.16

1.17

g/l

0.75

1207

5508

Diseases of the respiratory system

1522

3660

2.12

135.37

1.8

1.6

1.19

1.16

g/l

1.63

1437

3493

Diabetic nephropathy, excluding more controls

482

1138

3.70

135.09

1.6

1.21

1.27

g/l

2.65

458

1092

Isolated proteinuria

201

295

8.13

134.98

2.9

1.4

1.20

1.18

g/l

0.40

196

282

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2749

8803

1.72

134.77

1.8

1.6

1.18

1.17

g/l

0.12

2632

8350

Other and unspecified iron deficiency

929

3919

2.45

133.63

1.8

1.6

1.16

1.17

g/l

0.38

886

3712

Acute tubulo-interstitial nephritis

1512

6615

2.01

132.32

1.8

1.6

1.19

1.17

g/l

0.88

1437

6284

Atrial fibrillation and flutter

737

1713

2.87

132.02

1.7

1.5

1.21

1.16

g/l

4.24

704

1627

Pericarditis

184

247

8.37

131.92

2.9

1.3

1.16

1.20

g/l

0.50

171

230

Spondylopathies

1897

6054

1.91

131.66

1.6

1.19

1.17

g/l

2.26

1799

5762

STROKE

1334

4319

2.15

131.66

1.8

1.6

1.20

1.17

g/l

2.39

1266

4107

Other acute lower respiratory infections

1374

6475

2.07

131.53

1.8

1.7

1.20

1.17

g/l

3.37

1307

6152

Undetermined asthma, excluding more controls

382

985

4.06

131.03

1.6

1.5

1.22

1.18

g/l

1.68

368

933

Rheumatism, unspecified

465

1387

3.54

129.35

1.9

1.6

1.23

1.19

g/l

1.82

445

1311

Other specified/unspecified necrotizing vasculopathies

127

110

15.07

129.03

2.4

1.1

1.20

g/l

0.09

122

105

Iron deficiency anaemia

1112

5058

2.23

128.73

1.8

1.6

1.16

1.17

g/l

0.48

1060

4795

Depression medications

743

1300

2.94

128.58

1.8

1.21

1.12

g/l

11.33

715

1245

Vocal cord dysfunction

344

728

4.39

128.30

1.7

1.2

1.16

1.18

g/l

0.74

319

694

Intestinal infectious diseases

2828

9753

1.68

128.17

1.8

1.7

1.17

g/l

0.06

2690

9286

Dorsopathies

2533

7497

1.74

127.33

1.7

1.18

1.17

g/l

1.80

2398

7157

Gout, idiopatic and unspecified

637

2298

2.88

126.83

1.4

1.5

1.23

1.16

g/l

7.10

607

2181

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

224

387

6.44

126.51

1.9

1.6

1.18

1.16

g/l

0.20

214

363

Viral infections characterized by skin and mucous membrane lesions

1140

5360

2.19

126.17

2.2

1.6

1.16

1.18

g/l

1.04

1086

5097

Other headache syndromes

1155

5459

2.17

125.88

1.8

1.7

1.19

1.16

g/l

3.52

1099

5203

Disturbances of skin sensation

851

3556

2.48

125.72

1.8

1.17

1.18

g/l

0.73

811

3397

Diarrhoea and gastroenteritis of presumed infectious origin

2513

9824

1.71

125.62

1.8

1.7

1.18

1.17

g/l

0.07

2401

9351

Idiopathic pulmonary fibrosis

268

547

5.27

125.04

1.7

1.4

1.19

1.16

g/l

0.74

260

515

Infections of the skin and subcutaneous tissue

1519

7863

1.96

124.93

2.0

1.6

1.18

1.17

g/l

0.32

1450

7499

Acute sinusitis

1392

6522

2.02

124.38

1.8

1.7

1.20

1.17

g/l

2.56

1324

6210

Asthma/COPD (KELA code 203)

2350

9431

1.74

124.17

1.6

1.7

1.21

1.16

g/l

11.09

2237

8975

Allergic asthma (mode), excluding more controls

628

2216

2.86

123.93

1.5

1.7

1.22

1.16

g/l

5.96

588

2120

Other diseases of blood and blood-forming organs, wide

675

2546

2.77

123.87

2.1

1.6

1.13

1.19

g/l

4.73

636

2412

Hypertensive heart and/or renal disease

603

1532

3.03

123.46

1.6

1.5

1.18

1.14

g/l

2.35

572

1459

Other disorders of fluid, electrolyte and acid-base balance

788

3034

2.55

123.18

1.7

1.6

1.14

1.16

g/l

1.55

746

2873

Biological medication for rheuma

599

2137

2.95

122.68

1.6

1.7

1.20

1.19

g/l

0.62

563

2026

Undetermined asthma

382

1032

3.87

122.67

1.6

1.5

1.22

1.17

g/l

2.06

368

979

Diseases of salivary glands

931

4090

2.36

122.55

2.1

1.7

1.17

1.18

g/l

0.75

894

3883

Implicit fungal Sepsis

267

555

5.22

122.30

1.7

1.5

1.18

1.19

g/l

0.05

248

526

Other disorders of skin and subcutaneous tissue, not elsewhere classified

449

1356

3.48

122.29

1.9

1.6

1.17

1.19

g/l

0.60

423

1276

Idiopathic urticaria

166

220

9.15

122.26

1.6

1.5

1.20

1.17

g/l

0.58

158

207

Osteoporosis

696

2489

2.71

121.82

2.2

1.5

1.14

1.19

g/l

3.69

665

2325

Anxiety disorders, excluding more controls

2119

7875

1.78

120.94

1.8

1.7

1.19

1.17

g/l

1.77

2009

7519

Bacterial pneumoniae

981

3861

2.30

120.36

1.9

1.5

1.19

1.17

g/l

0.63

917

3662

Anxiety disorders

2300

9435

1.73

119.69

1.8

1.7

1.19

1.18

g/l

0.93

2181

8999

Neurotic, stress-related and somatoform disorders

2282

9389

1.73

119.30

1.8

1.7

1.19

1.18

g/l

0.90

2164

8955

Migraine with aura

774

3174

2.53

119.01

1.9

1.8

1.17

1.15

g/l

1.05

733

3041

Pulmonary heart disease, diseases of pulmonary circulation

817

3431

2.46

118.82

1.8

1.5

1.22

1.17

g/l

4.15

769

3240

Gastro-oesophageal reflux disease

1669

7823

1.88

118.81

1.8

1.6

1.17

1.18

g/l

0.60

1576

7460

Complications of procedures, not elsewhere classified

2004

9498

1.78

118.74

1.8

1.7

1.18

1.17

g/l

0.59

1895

9046

Diseases of the eye and adnexa

2036

5695

1.82

117.57

1.8

1.6

1.18

1.17

g/l

0.08

1952

5432

Allergic asthma (mode)

628

2281

2.77

117.34

1.5

1.7

1.22

1.16

g/l

6.16

588

2186

Chronic ulcer of skin, not elsewhere classified

250

508

5.30

117.31

2.0

1.3

1.21

1.18

g/l

0.57

235

481

Abnormal findings on examination of urine, without diagnosis

226

425

5.97

117.05

2.8

1.4

1.20

1.19

g/l

0.10

220

403

Ischemic heart diseases

1928

6475

1.82

116.16

1.7

1.6

1.20

1.18

g/l

1.95

1833

6163

Non-ischemic cardiomyopathy

737

2354

2.60

115.49

1.8

1.5

1.15

1.18

g/l

1.75

699

2220

Temporal arteritis

172

249

7.77

115.47

1.8

1.2

1.28

1.19

g/l

2.36

162

232

Syncope and collapse

953

3654

2.28

114.98

1.7

1.5

1.16

g/l

0.21

907

3463

Heart failure and coronary heart disease

939

2914

2.34

114.86

1.6

1.5

1.15

1.17

g/l

0.81

896

2748

Other general symptoms and signs

225

420

5.77

114.85

1.7

1.6

1.19

1.15

g/l

0.82

213

395

Liquid cancers, helper endpoint

965

3821

2.27

113.88

1.7

1.6

1.16

1.18

g/l

1.77

918

3607

Other and unspecified coagulation defects

256

551

5.17

113.51

3.3

1.8

1.13

1.18

g/l

1.23

247

523

Chronic sinusitis

1131

5517

2.10

113.45

1.7

1.20

1.17

g/l

2.43

1076

5269

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

350

948

3.96

113.32

1.6

1.7

1.22

1.18

g/l

1.66

328

899

Kidney transplant status

244

505

5.35

113.10

2.0

1.4

1.03

1.19

g/l

11.00

231

476

Non-allergic asthma (mode), excluding more controls

467

1493

3.20

112.76

1.8

1.5

1.21

1.18

g/l

1.17

445

1412

Secondary right heart disease

195

330

6.58

112.55

1.8

1.5

1.18

1.17

g/l

0.11

187

315

Bacterial pneumonia, not elsewhere classified

922

3637

2.29

112.24

1.9

1.5

1.19

1.17

g/l

0.71

862

3448

Venous thromboembolism

1285

6349

2.00

112.18

1.8

1.6

1.21

1.18

g/l

2.78

1219

6016

Acute bronchitis

1039

4830

2.16

112.12

1.8

1.6

1.21

1.17

g/l

3.26

990

4583

Oxycodone

879

3501

2.33

112.02

1.7

1.5

1.21

1.16

g/l

4.15

825

3315

Atrial fibrillation and flutter with reimbursement

567

1221

3.04

111.67

1.6

1.5

1.21

1.16

g/l

3.29

540

1156

Gout, unspecified

527

1843

2.98

111.36

1.4

1.23

1.16

g/l

5.92

498

1744

Percutaneous Coronary Intervention

1808

6169

1.83

111.13

1.6

1.20

1.18

g/l

0.99

1717

5866

Other pleural conditions

315

802

4.15

110.65

2.0

1.4

1.07

1.18

g/l

5.07

303

755

Diabetic nephropathy

485

1609

3.14

110.53

1.6

1.5

1.21

1.25

g/l

1.64

461

1526

Gastrointestinal diseases

1470

3768

1.99

110.46

1.9

1.7

1.17

g/l

0.21

1390

3610

Coronary revascularization (ANGIO or CABG)

1807

6172

1.83

110.24

1.6

1.20

1.18

g/l

1.08

1716

5869

Other coagulation defects

310

788

4.25

110.10

3.0

1.7

1.14

1.17

g/l

1.05

300

744

Chronic rhinitis, nasopharyngitis and pharyngitis

890

4015

2.28

109.71

1.8

1.7

1.20

1.17

g/l

2.20

839

3835

Gonarthrosis [arthrosis of knee](FG)

1365

4023

2.00

109.17

1.6

1.2

1.22

1.19

g/l

2.65

1297

3805

Hypothyroidism, drug reimbursement

403

804

3.66

109.04

1.8

1.7

1.21

1.11

g/l

7.33

381

774

Gout, strict definition

470

1565

3.13

108.51

1.4

1.5

1.25

1.15

g/l

7.14

444

1483

Heart failure and bmi 25plus

793

2222

2.48

108.32

1.6

1.4

1.19

1.23

g/l

2.27

751

2106

Bacterial pneumonia (organism specified)

1061

4644

2.12

107.62

1.9

1.6

1.19

1.17

g/l

0.83

993

4397

Valvular heart disease excluding rheumatic fever

1043

3552

2.17

107.09

1.8

1.5

1.13

1.19

g/l

8.98

988

3359

Sciatica+with lumbago

1258

5956

1.99

107.00

1.6

1.7

1.21

1.17

g/l

5.18

1193

5677

Exposure to unspecified factor

2426

10748

1.65

106.98

1.7

1.20

1.17

g/l

4.28

2305

10234

Symptoms and signs involving the digestive system and abdomen

2343

7019

1.70

106.77

1.7

1.18

1.17

g/l

1.63

2225

6698

Non-rheumatic valve diseases

1036

3522

2.17

106.64

1.8

1.5

1.13

1.19

g/l

9.51

982

3332

Asthma and allergy

391

1161

3.46

106.24

1.6

1.7

1.22

1.14

g/l

6.03

366

1114

Other pulmonary heart/vessel disease

201

373

5.94

105.13

1.8

1.4

1.18

1.17

g/l

0.15

193

358

Non-allergic asthma (mode)

467

1556

3.07

105.03

1.8

1.5

1.21

1.17

g/l

1.70

445

1474

Preparatory care for dialysis

206

394

5.85

104.72

1.8

1.5

1.07

1.17

g/l

4.08

195

373

Noninfective enteritis and colitis

1204

6179

1.99

104.55

1.7

1.19

1.17

g/l

1.06

1145

5889

Other symptoms and signs involving the nervous and musculoskeletal systems

1099

5501

2.05

103.07

1.8

1.7

1.17

1.18

g/l

0.56

1056

5227

Emergency coronary revascularization (for ACS)

1897

6669

1.76

102.28

1.6

1.20

1.18

g/l

0.95

1804

6332

Other/unspecified dorsalgia

937

4393

2.17

102.05

1.7

1.21

1.17

g/l

3.22

887

4192

Other and unspecified drugs and medicaments

323

893

3.88

101.61

1.6

1.7

1.22

1.18

g/l

1.31

301

846

Spondylosis

1235

5210

1.97

101.01

1.6

1.19

1.18

g/l

0.84

1174

4955

Major coronary heart disease event

1876

6566

1.75

100.04

1.6

1.20

1.18

g/l

1.83

1779

6242

Asthma and allergy, excluding more controls

391

1206

3.33

99.97

1.6

1.7

1.22

1.15

g/l

4.95

366

1154

Abdominal and pelvic pain

2304

7019

1.67

99.61

1.7

1.19

1.17

g/l

2.97

2180

6698

Depression

2334

9804

1.64

99.12

1.7

1.20

1.17

g/l

4.70

2216

9353

DVT of lower extremities and pulmonary embolism

973

4705

2.11

98.95

1.8

1.6

1.21

1.18

g/l

2.79

917

4452

Arthrosis

1473

4333

1.89

98.95

1.6

1.21

1.17

g/l

3.75

1408

4112

Disorders of skin appendages

1260

6692

1.92

98.86

1.9

1.7

1.17

1.18

g/l

0.39

1192

6389

Other intervertebral disc disorders

1904

6697

1.74

98.70

1.6

1.7

1.20

1.17

g/l

3.22

1798

6380

Other and unspecified immunodeficiencies with predominantly antibody defects

122

147

10.97

98.63

1.8

1.5

1.15

1.19

g/l

0.53

113

141

Zoster [herpes zoster]

1177

6021

1.97

98.60

2.1

1.6

1.15

1.18

g/l

3.19

1132

5701

Symptoms and signs involving cognition, perception, emotional state and behaviour

2311

9759

1.64

98.48

1.7

1.18

g/l

0.10

2176

9311

Endocrine, nutritional and metabolic diseases

1936

5700

1.74

97.93

1.8

1.21

1.13

g/l

22.72

1841

5436

Genitourinary diseases

1287

3299

1.99

96.92

1.7

1.5

1.17

1.18

g/l

0.08

1235

3129

Bleeding

1856

7776

1.73

96.79

1.8

1.6

1.18

g/l

0.10

1759

7399

Dermatographic urticaria

280

727

4.16

96.67

1.6

1.8

1.18

1.17

g/l

0.19

261

685

Shoulder lesions

1683

5797

1.79

96.06

1.7

1.6

1.20

1.17

g/l

3.47

1598

5504

Osteoporosis with pathological fracture (FG)

199

394

5.35

95.81

2.2

1.2

1.13

1.20

g/l

2.04

191

368

Allergic purpura

173

307

6.41

95.71

1.6

1.5

1.22

1.19

g/l

0.44

161

292

Mood [affective] disorders

2455

10048

1.61

95.68

1.8

1.7

1.20

1.17

g/l

5.59

2329

9583

Mood disorders, excluding more controls

2240

8226

1.65

95.54

1.8

1.7

1.20

1.17

g/l

5.69

2122

7843

Mood disorders

2459

10055

1.60

95.52

1.8

1.7

1.20

1.17

g/l

5.75

2333

9588

Explicit bacterial Sepsis

311

869

3.76

95.45

2.3

1.5

1.14

1.18

g/l

1.26

295

826

Mycoses

718

3143

2.36

95.41

1.8

1.7

1.19

1.18

g/l

0.49

685

2982

Abnormalities of heart beat

832

3790

2.20

94.52

2.0

1.6

1.17

g/l

0.16

793

3605

All influenza

626

2587

2.49

94.36

1.9

1.6

1.17

g/l

0.13

589

2454

Other disorders of urethra and urinary system

1698

7107

1.75

94.10

1.7

1.19

1.17

g/l

1.18

1591

6767

Wegener granulomatosis

113

130

10.59

93.35

2.6

1.1

1.21

1.20

g/l

0.09

105

125

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2323

9505

1.61

92.54

1.7

1.16

1.18

g/l

1.63

2205

9053

Atopic dermatitis

1436

6579

1.82

92.44

1.8

1.7

1.18

1.17

g/l

0.05

1366

6267

Giant cell arteritis with polymyalgia rheumatica

172

315

6.11

91.71

1.8

1.5

1.28

1.16

g/l

4.06

162

296

Irritable bowel syndrome

760

3469

2.26

91.19

1.7

1.19

1.18

g/l

0.36

728

3293

Symptoms and signs concerning food and fluid intake

291

801

3.79

90.96

2.0

1.5

1.12

1.16

g/l

1.43

276

751

Rosacea

395

1325

3.15

90.83

2.2

1.7

1.16

1.19

g/l

0.83

379

1250

Other noninfective gastroenteritis and colitis

673

2927

2.37

90.58

1.8

1.7

1.19

1.18

g/l

0.37

646

2783

Visual disturbances and blindness

1265

6922

1.87

90.52

1.8

1.6

1.20

1.17

g/l

2.45

1207

6570

Pulmonary embolism

705

3135

2.31

89.94

1.8

1.6

1.23

1.18

g/l

4.51

662

2962

Other arrhythmias

1465

6238

1.80

89.87

1.8

1.6

1.16

1.19

g/l

1.82

1399

5934

Nausea and vomiting

682

2926

2.35

89.78

1.8

1.6

1.18

1.16

g/l

0.54

644

2797

Thrombocytopenia, unspecified

251

636

4.23

89.32

2.7

1.5

1.08

1.18

g/l

4.94

234

607

Psoriatic and enteropathic arthropathies

301

860

3.65

89.14

1.7

1.2

1.23

1.20

g/l

0.97

290

811

Diseases of the digestive system

1053

5431

1.97

89.03

1.8

1.6

1.16

1.17

g/l

0.91

998

5156

Peripheral artery disease

883

3372

2.13

88.74

1.5

1.17

g/l

0.02

842

3179

Visual disturbances

1193

6456

1.89

88.69

1.9

1.7

1.20

1.17

g/l

2.30

1139

6130

Persons encountering health services for examination and investigation

1394

3785

1.87

88.69

1.8

1.5

1.17

1.18

g/l

0.51

1318

3627

Disorders of conjunctiva

2021

10058

1.64

88.61

1.9

1.7

1.18

1.17

g/l

0.63

1935

9570

Pulmonary heart disease

705

3162

2.29

88.12

1.8

1.6

1.23

1.17

g/l

4.69

662

2987

Diseases of liver

849

4105

2.12

87.76

1.8

1.6

1.20

1.19

g/l

0.54

799

3905

Care involving use of rehabilitation procedures

1507

8041

1.75

86.99

1.9

1.6

1.19

1.18

g/l

0.67

1420

7645

Other arthrosis

1047

3688

2.00

86.94

1.7

1.5

1.20

1.18

g/l

1.74

1002

3497

Disorders of lipoprotein metabolism and other lipidaemias

1766

6497

1.71

86.80

1.5

1.6

1.24

1.18

g/l

11.97

1667

6184

Spondylopathies (FG)

347

1102

3.27

86.73

1.7

1.2

1.20

1.19

g/l

0.24

330

1041

Migraine with aura and triptan purchases

527

2102

2.62

86.64

1.8

2.0

1.19

1.16

g/l

1.21

502

2003

Migraine without aura

611

2602

2.43

86.63

1.9

1.19

1.15

g/l

2.28

581

2494

Tumor necrosis factor alpha inhibitors

498

1933

2.69

86.62

1.5

1.7

1.20

1.19

g/l

0.49

466

1834

Sleep apnoea

2157

8760

1.62

86.59

1.6

1.7

1.26

1.16

g/l

45.35

2051

8329

Hypertensive Renal Disease

141

224

6.83

86.12

1.5

1.4

1.16

1.13

g/l

0.45

133

211

Dysphagia

601

2547

2.43

85.81

1.7

1.5

1.17

g/l

0.16

575

2420

Other and unspecified rosacea

314

952

3.52

85.80

2.2

1.7

1.16

1.18

g/l

0.42

299

901

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2192

8862

1.61

85.42

1.8

1.6

1.17

1.18

g/l

0.61

2088

8424

Coxarthrosis [arthrosis of hip](FG)

916

3149

2.08

85.00

1.7

1.2

1.20

1.19

g/l

0.51

871

2979

Disorders of the thyroid gland

2206

9110

1.60

84.65

1.8

1.7

1.20

1.17

g/l

4.38

2086

8672

Zoster [herpes zoster]

489

1900

2.67

84.53

2.4

1.5

1.16

1.19

g/l

1.33

469

1776

Other diseases of urinary system

2328

8346

1.59

84.52

1.8

1.7

1.18

1.17

g/l

0.43

2202

7967

Streptococcal septicaemia

253

669

3.98

84.31

2.2

1.5

1.16

g/l

0.07

237

633

Fungal Sepsis

170

332

5.61

84.07

1.8

1.5

1.19

g/l

0.03

159

314

Symptoms and signs involving the urinary system

1705

7809

1.69

83.60

1.7

1.6

1.17

1.18

g/l

0.26

1608

7446

Conjunctivitis

1854

9553

1.65

83.54

1.9

1.7

1.18

1.17

g/l

0.76

1775

9086

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1414

8075

1.76

83.51

1.8

1.6

1.18

1.17

g/l

0.37

1330

7688

Hypothyroidism, other/unspecified

2093

8660

1.61

83.30

1.8

1.7

1.19

1.17

g/l

3.91

1970

8248

Budesonide

345

1119

3.20

83.24

1.6

1.4

1.19

1.17

g/l

0.76

323

1063

Seropositive rheumatoid arthritis, strict definition

445

1667

2.79

83.11

1.6

1.15

1.19

g/l

2.27

424

1569

Candidiasis

778

3725

2.15

82.82

1.8

1.7

1.17

g/l

0.12

737

3536

Atherosclerosis, excluding cerebral and coronary sclerosis

813

3072

2.14

82.77

1.5

1.17

g/l

0.03

772

2894

Anxiety (asthma-related co-morbidities)

1522

6898

1.74

82.52

1.8

1.19

1.17

g/l

1.12

1449

6582

All anxiety disorders

1556

7257

1.72

82.45

1.8

1.7

1.19

1.18

g/l

0.79

1481

6914

Other diseases of upper respiratory tract

2476

8367

1.56

82.21

1.7

1.18

1.17

g/l

1.67

2343

7976

Hypothyreosis and Thyroxine purchase for inclusion criteria

2165

9045

1.59

81.80

1.8

1.7

1.19

1.17

g/l

3.66

2039

8615

Sleep disorders (combined)

2602

8971

1.54

81.66

1.6

1.7

1.21

1.16

g/l

17.97

2469

8529

Continuous positive airway pressure

426

1300

2.84

80.68

1.7

1.5

1.24

1.16

g/l

5.55

394

1240

Acquired haemolytic anaemia

136

226

6.90

80.65

3.5

1.4

0.99

1.18

g/l

8.84

129

215

Other nutritional deficiencies

1621

9233

1.68

80.60

1.6

1.8

1.31

1.15

g/l

79.07

1546

8795

Sleep apnoea, including avohilmo

2267

9048

1.57

80.44

1.6

1.7

1.26

1.16

g/l

52.37

2154

8610

Diseases of the myoneural junction and muscle

348

1163

3.13

80.23

2.5

1.5

1.14

1.18

g/l

1.86

334

1096

Other CVD (FINNGEN)

269

566

3.82

79.69

1.6

1.18

1.16

g/l

0.58

251

533

Vasomotor and allergic rhinitis

965

4961

1.95

79.10

1.6

1.8

1.19

1.17

g/l

1.12

908

4753

Other anxiety disorders

1192

5754

1.83

78.74

1.8

1.19

1.17

g/l

1.65

1135

5489

Implicit fungal Sepsis

159

311

5.62

78.57

1.8

1.5

1.18

1.19

g/l

0.16

148

295

Other functional intestinal disorders

1042

5189

1.90

78.31

1.8

1.6

1.17

g/l

0.04

991

4932

Other antidepressants

2337

7746

1.56

78.10

1.7

1.20

1.16

g/l

8.30

2236

7377

Cerebrovascular diseases

1555

6513

1.70

77.65

1.8

1.6

1.20

1.18

g/l

1.48

1480

6180

Disorders of other endocrine glands

1075

5785

1.87

77.00

2.0

1.7

1.19

1.17

g/l

0.71

1015

5498

5-aminosalicylic acid

468

1857

2.59

76.96

1.6

1.4

1.19

1.17

g/l

0.69

441

1775

Other/unspecified rheumatoid arthritis

354

1224

3.03

76.87

2.0

1.5

1.11

1.19

g/l

4.18

329

1160

Other reaction to severe stress, and adjustment disorders

965

5113

1.93

76.78

2.1

1.8

1.18

g/l

0.33

921

4882

Paroxysmal tachycardia

499

1687

2.54

76.01

1.7

1.6

1.18

1.15

g/l

1.00

475

1598

Dizziness and giddiness

1707

8359

1.64

75.82

1.6

1.7

1.18

g/l

0.45

1616

7965

Hypermobility syndrome

208

519

4.31

75.81

1.7

1.2

1.20

1.22

g/l

0.37

196

483

Atopic dermatitis, strict definition with reimbursement

776

3693

2.08

75.64

1.8

1.18

1.17

g/l

0.49

742

3525

Disorders of sclera, cornea, iris and ciliary body

1292

7513

1.75

75.29

1.9

1.6

1.18

g/l

0.12

1227

7153

Haemolytic anaemias

159

328

5.36

74.14

3.2

1.5

1.00

1.20

g/l

11.11

151

309

Other bacterial intestinal infections

465

1883

2.55

73.68

1.8

1.6

1.15

1.19

g/l

1.74

431

1784

Kela reimbursement Agammaglobulinemia (D80-84)

11.86

73.28

2.0

1.4

1.23

1.19

g/l

0.36

Early onset COPD, excluding more controls

396

1481

2.74

73.24

1.6

1.3

1.20

1.18

g/l

0.78

373

1401

Somatoform disorder

476

1963

2.52

72.78

1.8

1.7

1.19

1.18

g/l

0.16

444

1861

Disorders resulting from impaired renal tubular function

160

338

5.23

72.58

2.1

1.5

1.11

1.19

g/l

2.10

150

321

Depression or dysthymia

1537

5070

1.70

72.16

1.7

1.20

1.17

g/l

4.28

1461

4836

Spondyloarthritis

430

1695

2.61

71.89

1.7

1.3

1.20

1.19

g/l

0.23

406

1601

Other bacterial intestinal infections

567

2547

2.29

70.86

1.7

1.6

1.15

1.18

g/l

1.25

523

2414

Disorders of synovium and tendon

1164

5822

1.78

70.60

1.7

1.6

1.18

1.17

g/l

0.60

1118

5536

Other skin changes

469

1948

2.49

70.47

1.7

1.6

1.17

1.18

g/l

0.45

449

1838

Rotator cuff syndrome

1260

5230

1.75

70.38

1.6

1.20

1.17

g/l

2.62

1195

4960

Other disorders of kidney and ureter

358

1309

2.86

70.11

1.7

1.5

1.16

1.19

g/l

1.04

341

1238

Primary_lymphoid and hematopoietic malignant neoplasms

557

2496

2.30

70.05

1.7

1.5

1.15

1.17

g/l

0.98

531

2358

Diverticular disease of intestine

1484

5712

1.68

69.65

1.6

1.19

g/l

0.37

1406

5425

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1166

6536

1.76

69.46

1.7

1.20

1.18

g/l

1.88

1085

6236

Hypertensive Heart Disease

456

1437

2.54

68.98

1.6

1.5

1.19

1.14

g/l

2.64

430

1369

Recurrent or chronic depression

984

3737

1.89

68.96

1.8

1.21

1.17

g/l

4.03

943

3574

Lumbar disc prolapse

1382

6363

1.69

68.34

1.6

1.7

1.19

1.17

g/l

1.90

1311

6071

Sequelae of external causes of morbidity and mortality

626

2971

2.17

68.24

1.6

1.20

1.18

g/l

1.19

593

2808

Hyperkalaemia

170

393

4.58

68.11

1.5

1.4

1.16

1.15

g/l

0.19

156

379

Persons encountering health services in other circumstances

943

5122

1.87

68.09

1.9

1.7

1.16

1.17

g/l

0.47

915

4865

COPD (mode)

530

1811

2.34

67.51

1.5

1.4

1.16

1.18

g/l

0.51

505

1709

Bacterial intestinal infections, IBD co-morbidities

465

1969

2.44

66.88

1.8

1.6

1.15

1.19

g/l

1.71

433

1859

Hyperlipidaemia, other/unspecified

781

3697

1.98

66.82

1.5

1.22

1.16

g/l

4.75

734

3512

Cystitis

1947

7506

1.56

66.80

1.8

1.7

1.18

1.17

g/l

0.71

1849

7156

Pure hypercholesterolaemia

1485

5921

1.66

66.53

1.5

1.6

1.24

1.17

g/l

11.70

1402

5638

Subjective visual disturbances

636

3072

2.13

66.25

2.0

1.7

1.21

1.18

g/l

1.39

609

2907

Other viral diseases

955

5248

1.84

66.02

2.0

1.8

1.17

g/l

0.27

906

5022

Other disorders of white blood cells

196

519

4.05

65.86

1.8

1.6

1.14

1.19

g/l

1.22

183

489

Convulsions, not elsewhere classified

486

2076

2.36

65.86

2.0

1.6

1.15

1.16

g/l

0.25

452

1976

ILD and respiratory illness in diseases classified elsewhere

17.04

65.36

2.8

1.2

1.21

1.19

g/l

0.11

Disorders of lens

1398

5264

1.68

65.29

1.9

1.5

1.18

1.19

g/l

0.43

1320

5005

Enterocolitis due to Clostridium difficile

285

956

3.11

65.25

1.8

1.5

1.15

1.18

g/l

0.78

266

904

Other diseases of lip and oral mucosa

941

5218

1.84

64.90

1.9

1.7

1.16

1.18

g/l

2.11

896

4955

Dermatitis due to substances taken internally

182

461

4.20

64.80

2.6

1.7

1.13

1.18

g/l

0.87

175

435

Viral pneumonia

327

1187

2.86

64.69

2.0

1.5

1.17

1.18

g/l

0.19

315

1127

Rash and other nonspecific skin eruption

294

1013

3.05

64.48

2.1

1.7

1.16

1.18

g/l

0.57

281

958

Ischaemic heart disease, wide definition

1568

6051

1.63

64.39

1.7

1.6

1.20

1.18

g/l

1.68

1491

5752

Bronchiectasis

228

676

3.56

64.33

1.6

1.5

1.17

1.18

g/l

0.17

218

634

Type 2 diabetes, wide definition

1657

6716

1.60

63.97

1.4

1.7

1.28

1.15

g/l

44.31

1575

6369

Cutaneous abscess, furuncle and carbuncle

643

3158

2.09

63.95

2.0

1.7

1.18

g/l

0.05

612

3000

Follow-up examination after treatment for conditions other than malignant neoplasms

915

3260

1.89

63.76

1.8

1.5

1.17

1.18

g/l

0.39

858

3126

L04AC Interleukin inhibitors

218

636

3.67

63.49

1.7

1.6

1.25

1.19

g/l

1.78

209

597

Mycoses

1913

11026

1.53

63.49

1.8

1.7

1.18

g/l

0.08

1822

10492

Pain in thoracic spine

400

1627

2.54

62.89

1.9

1.7

1.17

1.18

g/l

0.27

384

1549

Insulin, combination of fast acting with intermediate-acting or long-acting

1278

7076

1.67

62.85

1.5

1.6

1.23

1.17

g/l

9.17

1211

6723

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1285

7820

1.67

62.84

1.8

1.6

1.18

g/l

0.19

1207

7439

Adalimumab

311

1126

2.90

62.36

1.5

1.7

1.21

1.19

g/l

0.59

291

1065

Other gastritis (incl. Duodenitis)

514

2340

2.26

62.19

1.6

1.5

1.17

1.19

g/l

0.90

482

2214

Other respiratory disorders and diseases

453

1958

2.38

62.03

1.6

1.5

1.20

1.16

g/l

1.60

426

1852

Other diseases of the respiratory system

453

1958

2.38

62.03

1.6

1.5

1.20

1.16

g/l

1.60

426

1852

Unspecified haematuria

861

3876

1.88

61.32

1.7

1.5

1.18

g/l

0.04

814

3677

Allergic rhinitis

787

4157

1.91

61.09

1.6

1.8

1.19

1.17

g/l

1.18

743

4005

Insulin, fast-acting

813

4390

1.89

60.91

1.5

1.7

1.19

1.17

g/l

1.46

772

4176

Cardiomyopathy

363

1431

2.61

60.72

1.5

1.4

1.17

1.20

g/l

0.95

343

1344

Gonarthrosis

1166

3867

1.74

60.57

1.5

1.22

1.17

g/l

5.79

1109

3668

Obesity and other hyperalimentation

1478

9048

1.60

60.50

1.5

1.8

1.33

1.15

g/l

92.21

1412

8614

Hypo-osmolality and hyponatraemia

386

1562

2.53

60.41

1.8

1.5

1.11

1.17

g/l

3.90

367

1477

Peripheral artery operations in Hilmo

281

975

2.98

60.26

1.6

1.4

1.14

1.16

g/l

0.33

269

918

Obesity

1471

9023

1.60

60.09

1.5

1.8

1.33

1.15

g/l

92.63

1405

8589

Temporomandibular joint disorders, including avohilmo

1112

6512

1.72

60.09

1.8

1.17

1.18

g/l

0.18

1058

6207

Symptoms and signs involving speech and voice

768

4098

1.92

60.01

1.8

1.6

1.18

g/l

0.04

726

3869

Other enthesopathies

660

3351

2.01

59.63

1.7

1.6

1.21

1.17

g/l

1.83

632

3182

Allergic urticaria

261

882

3.11

59.34

1.9

1.8

1.24

1.17

g/l

3.10

252

828

Insulin medication

1278

6589

1.66

59.33

1.5

1.7

1.23

1.15

g/l

14.66

1211

6269

Chronic gastritis

582

2830

2.10

59.33

1.8

1.5

1.16

1.19

g/l

1.14

554

2673

Juvenile arthritis (FINNGEN)

158

385

4.36

59.29

2.5

1.2

1.12

1.20

g/l

2.16

153

357

Hypothyroidism, strict autoimmune, 3 medication purchases required

1897

8527

1.52

59.26

1.8

1.7

1.20

1.17

g/l

4.43

1794

8123

16.95

59.00

2.9

1.3

1.21

1.19

g/l

0.20

Diagnoses used for exclusion with ILD

570

2762

2.11

58.75

1.6

1.20

1.18

g/l

0.64

548

2611

Amputation

240

775

3.22

58.59

1.6

1.4

1.15

1.16

g/l

0.26

226

730

Intracranial trauma

1172

4913

1.70

58.44

1.8

1.7

1.19

1.16

g/l

1.99

1108

4682

Small fibre neuropathy

130

278

5.19

58.30

2.1

1.4

1.11

1.20

g/l

2.39

123

262

Candidiasis

381

1574

2.52

58.24

1.8

1.17

g/l

0.02

363

1488

Primary biliary cholangitis (PBC)

120

7.78

58.19

1.8

1.1

1.20

1.27

g/l

0.97

111

Benign neoplasm of colon, rectum, anus and anal canal

1266

6771

1.65

57.98

1.6

1.18

g/l

0.05

1206

6417

Thyroiditis, ILD-related definition

307

1146

2.78

57.75

2.1

1.3

1.17

1.20

g/l

0.97

297

1082

Concussion

1020

4832

1.75

57.67

1.7

1.18

1.16

g/l

1.72

964

4604

Other viral diseases

734

3917

1.91

56.81

2.0

1.7

1.16

1.17

g/l

0.37

697

3744

Any mental disorder

2407

8379

1.45

56.75

1.8

1.7

1.19

1.17

g/l

3.23

2287

7987

Fibrosis and cirrhosis of liver

222

702

3.33

56.58

1.5

1.14

1.18

g/l

1.07

208

667

Reactive arthropathies, FINNGEN

183

511

3.74

56.41

2.6

1.2

1.20

1.19

g/l

0.19

175

482

Noninfectious colitis NAS

366

1507

2.52

56.25

1.9

1.7

1.18

g/l

0.01

358

1431

Insulin, fast-acting or short human

815

4515

1.84

56.24

1.5

1.7

1.19

1.17

g/l

1.17

774

4293

Other neurological diseases

1487

7516

1.58

55.84

1.7

1.6

1.18

g/l

0.07

1408

7139

Insulin, intermediate and long-acting

1117

6569

1.68

55.82

1.4

1.6

1.23

1.17

g/l

8.56

1057

6238

373

1560

2.48

55.39

1.8

1.7

1.24

1.18

g/l

2.73

350

1483

Myocarditis

134

302

4.66

55.32

2.0

1.6

1.18

g/l

0.02

128

288

Papulosquamous disorders

874

4973

1.79

55.30

1.6

1.7

1.23

1.18

g/l

4.55

838

4719

Coronary atherosclerosis

1222

4720

1.66

54.73

1.7

1.5

1.18

g/l

0.02

1163

4485

Benign neoplasm: Colon

1074

6175

1.69

54.65

1.6

1.18

g/l

0.09

1023

5848

Reactive arthropathies

221

713

3.22

54.14

2.6

1.5

1.20

1.19

g/l

0.17

210

668

Migraine without aura and triptan purchases

474

2218

2.21

53.95

1.8

1.9

1.18

1.17

g/l

0.70

453

2123

Hernia of abdominal wall, postoperative

358

1482

2.47

53.91

1.5

1.18

g/l

0.03

331

1428

Respiratory insufficiency

168

454

3.82

53.83

1.6

1.3

1.20

1.17

g/l

0.57

156

423

Spinal stenosis

958

4229

1.75

53.36

1.5

1.6

1.20

1.18

g/l

1.10

906

4005

Other or ill-defined heart diseases

154

397

4.07

53.32

1.8

1.5

1.16

1.20

g/l

0.69

145

374

Functional dyspepsia

618

3193

1.98

53.28

1.8

1.6

1.21

1.19

g/l

0.93

583

3036

Migraine, single triptan purchase ok & required. ICD-code if available is included

1769

8041

1.51

53.26

1.8

1.17

1.18

g/l

0.65

1691

7667

Triptan medication for migraine, single purchase ok

1769

8041

1.51

53.26

1.8

1.17

1.18

g/l

0.65

1691

7667

Diaphragmatic hernia

766

4239

1.84

53.24

1.9

1.6

1.20

1.18

g/l

0.63

721

4024

Triptan medication for migraine, min. 3 purchases

1393

6818

1.58

53.00

1.8

1.17

1.18

g/l

0.72

1331

6511

Cellulitis

513

2488

2.12

52.91

2.0

1.6

1.20

1.18

g/l

0.83

493

2358

Later onset COPD, excluding more controls

335

1019

2.59

52.90

1.3

1.15

1.17

g/l

0.56

317

947

Other complications of surgical and medical care, not elsewhere classified

285

1074

2.77

52.85

1.7

1.6

1.19

1.18

g/l

0.16

272

1018

Anaemia in chronic diseases classified elsewhere

104

200

5.76

52.63

2.2

1.4

1.02

1.17

g/l

3.66

189

Internal derangement of knee

705

3791

1.88

52.57

1.7

1.6

1.20

1.17

g/l

1.79

668

3605

Inflammatory diseases of the central nervous system

246

862

2.99

52.43

3.5

1.6

1.16

1.18

g/l

0.42

230

814

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1283

7934

1.60

52.41

1.9

1.7

1.18

g/l

0.13

1218

7547

Pain and other conditions associated with female genital organs and menstrual cycle

558

2568

2.05

52.05

1.9

1.8

1.17

1.18

g/l

0.22

530

2437

Cervicobrachial syndrome

513

2504

2.10

51.95

1.5

1.7

1.19

1.18

g/l

0.11

484

2377

Pruritus

282

1067

2.74

51.70

2.0

1.8

1.16

1.18

g/l

0.42

270

1006

Dentofacial anomalies [including malocclusion]

1614

8644

1.52

51.65

1.8

1.17

1.18

g/l

0.47

1526

8242

Peripheral arterial reconstruction

343

1425

2.47

51.45

1.5

1.4

1.17

1.15

g/l

0.45

328

1343

Coxarthrosis

853

3177

1.80

51.21

1.7

1.5

1.20

1.18

g/l

1.44

811

3015

Idiopathic thrombocytopenic purpura

127

296

4.70

51.08

3.8

1.5

1.08

1.18

g/l

3.10

119

282

Voice disturbances

625

3292

1.95

51.02

1.8

1.7

1.18

g/l

0.17

594

3110

Obesity due to excess calories

1094

6755

1.65

51.02

1.5

1.8

1.34

1.15

g/l

69.01

1048

6437

Other viral diseases, not elsewhere classified

661

3533

1.90

50.60

2.0

1.7

1.17

g/l

0.19

625

3378

Allergic conjunctivitis

1340

8460

1.57

50.54

1.9

1.8

1.18

g/l

0.40

1272

8054

Carpal tunnel syndrome

1304

7376

1.58

50.52

1.5

1.7

1.20

1.18

g/l

1.91

1256

7012

Benign neoplasms

2126

8170

1.45

50.47

1.8

1.7

1.18

1.17

g/l

1.13

2023

7798

Soft tissue disorders related to use, overuse and pressure

557

2845

2.00

49.57

1.9

1.5

1.19

1.18

g/l

0.51

522

2690

Stroke, excluding SAH

1143

5177

1.63

49.45

1.7

1.5

1.20

1.18

g/l

1.92

1087

4903

Meniscus derangement

973

3883

1.71

49.40

1.6

1.5

1.19

1.18

g/l

1.10

929

3677

Other diseases of arteries and capillaries

222

759

3.04

49.28

1.7

1.6

1.16

1.19

g/l

0.45

207

715

Inflammatory bowel disease

732

4100

1.82

48.99

1.6

1.7

1.19

1.18

g/l

0.56

693

3910

Other encephalitis

119

273

4.78

48.87

4.8

1.5

1.09

1.18

g/l

2.70

111

261

Stroke, including SAH

1212

5549

1.61

48.81

1.7

1.5

1.20

1.18

g/l

1.99

1151

5265

Amputation of toe

181

553

3.43

48.72

1.7

1.3

1.13

1.17

g/l

0.90

174

525

Chronic apical periodontitis

2433

9983

1.40

48.38

1.7

1.19

1.17

g/l

2.35

2327

9485

Constipation

1875

8986

1.46

48.32

1.7

1.6

1.18

g/l

0.05

1777

8558

Cervicalgia

455

2183

2.13

48.26

1.7

1.18

g/l

0.03

436

2065

Cervical disc disorders

732

4116

1.81

48.18

1.5

1.6

1.20

1.18

g/l

0.96

693

3922

Collagenous colitis

255

955

2.79

47.96

1.9

1.7

1.19

1.18

g/l

0.38

242

905

Major coronary heart disease event excluding revascularizations

1093

4485

1.65

47.87

1.7

1.5

1.20

1.18

g/l

0.66

1033

4255

Phlebitis and thrombophlebitis (not including DVT)

513

2584

2.03

47.74

2.0

1.6

1.18

1.19

g/l

0.35

486

2451

Sequelae of other external causes

178

548

3.44

47.58

1.5

1.6

1.21

1.18

g/l

0.47

169

518

COPD

811

3823

1.76

47.27

1.5

1.6

1.17

g/l

0.01

766

3597

Childhood asthma (age<16), excluding more controls

305

960

2.56

47.13

1.9

1.15

1.13

g/l

0.37

283

930

Inflammatory diseases of female pelvic organs

1446

7048

1.53

47.10

1.8

1.18

g/l

0.11

1365

6710

Coeliac disease

328

1396

2.44

47.02

2.2

1.8

1.13

1.18

g/l

2.22

315

1328

Factors influencing health status and contact with health services

552

1359

2.06

46.79

1.5

1.19

g/l

0.11

521

1300

Disorders of muscles

245

908

2.79

46.74

1.7

1.6

1.21

1.18

g/l

0.73

239

858

Idiopathic gout

217

755

2.99

46.72

1.5

1.4

1.25

1.16

g/l

3.71

212

711

Oxicams

486

1310

2.15

46.68

1.8

1.19

1.14

g/l

2.95

463

1240

Iridocyclitis

521

2661

2.01

46.62

1.9

1.7

1.18

1.19

g/l

0.13

502

2527

Psoriatic arthropathies

236

859

2.84

46.59

1.6

1.5

1.24

1.19

g/l

1.63

227

811

Encephalitis

122

296

4.49

46.58

4.7

1.5

1.09

1.18

g/l

2.77

114

283

Acute generalized exanthematous pustulosis

156

449

3.71

46.53

2.6

1.6

1.15

1.19

g/l

0.75

149

423

Use of hypnotics and sedatives

2269

9344

1.41

46.41

1.7

1.19

1.18

g/l

0.74

2164

8890

Disorders of parathyroid gland

446

2130

2.12

46.34

2.1

1.5

1.16

1.19

g/l

1.34

417

2001

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1067

5320

1.63

46.33

1.4

1.6

1.27

1.15

g/l

28.79

1009

5045

Herpesviral [herpes simplex] infections

602

3238

1.90

46.13

2.0

1.7

1.16

1.18

g/l

1.36

575

3087

Childhood asthma (age<16)

305

972

2.53

46.00

1.9

1.15

1.13

g/l

0.43

283

943

Drug-induced cataract

109

247

4.90

45.69

3.1

1.5

1.14

1.21

g/l

1.33

103

233

Disorders of mineral metabolism

221

791

2.91

45.26

1.6

1.18

1.17

g/l

0.18

208

760

Diseases of the ear and mastoid process

2542

9327

1.38

45.20

1.8

1.7

1.17

1.18

g/l

0.18

2413

8884

Volume depletion

211

738

2.95

44.84

1.5

1.15

1.16

g/l

0.23

198

701

Sarcoidosis

333

1457

2.36

44.80

1.6

1.20

1.19

g/l

0.22

321

1380

Other diseases of liver

430

2083

2.12

44.73

1.8

1.6

1.24

1.19

g/l

1.77

406

1973

Dermatopolymyositis, unspecified

13.77

44.39

1.8

1.0

1.11

1.26

g/l

2.31

Ischaemic Stroke, excluding all haemorrhages

1043

4850

1.62

44.08

1.7

1.5

1.20

1.17

g/l

1.92

987

4588

Senile cataract

1174

4590

1.59

43.75

1.7

1.5

1.18

1.19

g/l

0.49

1107

4362

Pollen allergy

502

2556

1.99

43.72

1.6

1.8

1.17

1.16

g/l

0.23

475

2453

Disorders of choroid and retina

1574

7644

1.48

43.70

1.7

1.6

1.17

1.18

g/l

1.05

1504

7251

Other infectious diseases

229

855

2.78

43.24

2.0

1.5

1.19

1.17

g/l

0.39

214

803

GI-bleeding

611

3364

1.85

43.17

1.7

1.5

1.16

1.17

g/l

0.50

576

3179

Crohn disease

340

1525

2.30

43.12

1.6

1.8

1.20

1.18

g/l

0.61

323

1448

Scleritis and episcleritis

198

689

3.03

43.03

2.1

1.7

1.24

1.18

g/l

1.89

187

651

Other viral diseases, not elsewhere classified

458

2297

2.04

42.94

2.1

1.7

1.16

1.17

g/l

0.52

434

2192

Deforming dorsopathies

588

3208

1.87

42.90

1.8

1.7

1.18

g/l

0.03

551

3050

Abnormal results of function studies

233

883

2.75

42.80

1.8

1.6

1.20

1.19

g/l

0.20

224

837

Other infectious diseases

197

683

3.01

42.79

2.1

1.5

1.18

g/l

0.03

185

646

Statin medication

1493

5660

1.50

42.48

1.8

1.7

1.23

1.14

g/l

23.14

1428

5388

Atopic dermatitis, strict definition

735

4207

1.75

42.42

1.8

1.9

1.18

1.17

g/l

0.27

702

4029

Disorders of calcium metabolism

172

558

3.23

42.05

1.7

1.5

1.17

1.16

g/l

0.08

162

534

Other external causes of accidental injury

1775

6183

1.45

42.00

1.8

1.7

1.18

1.17

g/l

1.68

1688

5911

Abnormal weight loss

231

880

2.73

42.00

2.1

1.5

1.11

1.18

g/l

2.37

221

833

Presence of other functional implants

1101

4883

1.58

41.69

1.6

1.17

1.19

g/l

1.25

1037

4624

Fall on same level

2468

9960

1.36

41.63

1.8

1.7

1.19

1.17

g/l

1.81

2349

9484

Other disorders of veins

860

5238

1.66

41.48

1.6

1.18

1.19

g/l

0.40

824

4961

Sequelae with surgical and medical care as external cause

447

2261

2.03

41.25

1.6

1.20

1.18

g/l

0.63

423

2131

Erythema multiforme

217

4.90

41.16

2.6

1.4

1.12

1.19

g/l

1.12

204

Accidents

1768

6183

1.45

40.98

1.8

1.7

1.19

1.17

g/l

2.03

1679

5911

Myocardial infarction

851

3610

1.68

40.97

1.6

1.5

1.19

1.18

g/l

0.67

809

3421

Osteomyelitis

172

568

3.17

40.82

1.7

1.4

1.19

g/l

0.01

167

539

Neoplasms

1682

6185

1.46

40.79

1.8

1.7

1.18

1.17

g/l

1.01

1605

5919

Adrenocortical insufficiency

133

377

3.79

40.76

1.5

1.6

1.28

1.19

g/l

1.90

121

356

Weight loss

248

993

2.59

40.71

2.0

1.5

1.11

1.18

g/l

2.56

237

941

Generalized skin eruption due to drugs and medicaments

135

388

3.72

40.42

2.8

1.6

1.12

1.20

g/l

1.61

128

366

Unspecified privation

272

1141

2.47

40.35

1.6

1.18

1.17

g/l

0.17

260

1079

Unspecified acute lower respiratory infection

340

1568

2.23

40.15

1.8

1.6

1.21

1.18

g/l

1.19

321

1487

Agranulocytosis

284

1219

2.42

40.07

2.5

1.6

1.09

1.18

g/l

5.13

269

1156

Other diseases of the digestive system

604

3394

1.81

39.95

1.6

1.5

1.15

1.17

g/l

0.77

570

3208

Selective serotonin reuptake inhibitors

2066

7792

1.40

39.81

1.7

1.20

1.16

g/l

6.77

1958

7421

Hypokalaemia

271

1141

2.45

39.74

1.6

1.19

1.17

g/l

0.40

255

1081

Diplopia

309

1380

2.31

39.60

1.6

1.19

1.18

g/l

0.24

299

1301

Presence of cardiac and vascular implants and grafts

774

3426

1.70

39.52

1.7

1.5

1.16

1.18

g/l

1.01

725

3242

Exposure to other specified factors

1599

10332

1.44

39.52

1.9

1.7

1.19

1.18

g/l

0.76

1522

9847

Other chronic obstructive pulmonary disease

749

3667

1.71

39.35

1.5

1.6

1.17

g/l

0.15

706

3449

Conjunctivitis (acute, non atopic)

630

3595

1.78

39.19

1.9

1.7

1.19

1.18

g/l

0.16

603

3431

Non-selective monoamine reuptake inhibitors

767

4456

1.68

39.17

1.6

1.22

1.17

g/l

4.72

723

4234

Progressive systemic sclerosis

11.85

39.15

3.0

1.4

1.05

1.13

g/l

0.80

Disorders of gallbladder, biliary tract and pancreas

2035

9334

1.39

39.08

1.7

1.24

1.16

g/l

21.98

1933

8881

Monoarthritis, not elsewhere classified

116

306

3.98

39.08

1.3

1.5

1.18

g/l

0.03

109

289

Coxibs

550

1525

1.93

39.07

1.6

1.8

1.19

1.13

g/l

3.27

516

1448

Anterior Iridocyclitis

460

2396

1.97

39.01

1.9

1.7

1.18

1.19

g/l

0.33

441

2272

723

3930

1.71

38.99

1.6

1.5

1.15

1.17

g/l

0.89

677

3707

Benzodiazepine use

2101

10610

1.38

38.87

1.7

1.19

1.17

g/l

2.31

1987

10103

Other symptoms and signs involving cognitive functions and awareness

861

4868

1.63

38.68

1.7

1.6

1.17

1.18

g/l

0.51

796

4625

Hallux valgus (acquired)

598

2390

1.83

38.66

1.7

1.5

1.15

1.18

g/l

1.81

567

2259

Other disorders of patella

350

1655

2.16

38.65

1.7

1.6

1.19

1.18

g/l

0.21

328

1570

Other embolism and thrombosis

296

1314

2.32

38.46

2.2

1.6

1.17

1.18

g/l

0.26

282

1235

Abnormalities of gait and mobility

269

1147

2.42

38.42

1.6

1.5

1.18

1.17

g/l

0.11

258

1084

Stomatitis and related lesions

458

2397

1.96

38.33

1.9

1.7

1.17

1.18

g/l

0.33

434

2278

Paracetamol or NSAID medication

341

752

2.32

38.26

1.5

1.7

1.18

1.12

g/l

2.50

325

712

Conduction disorders

523

2284

1.89

38.26

1.5

1.16

1.19

g/l

1.68

487

2141

Diabetic retinopathy, excluding more controls

521

1535

1.94

38.17

1.4

1.6

1.20

1.28

g/l

6.93

497

1470

Other erythematous conditions

116

314

3.95

37.95

2.0

1.6

1.23

1.18

g/l

0.94

111

297

Enthesopathies of lower limb, excluding foot

471

2493

1.93

37.93

1.7

1.21

1.18

g/l

1.11

443

2374

Acute and subacute iridocyclitis

430

2212

1.99

37.84

1.8

1.7

1.18

1.19

g/l

0.17

412

2100

Other disorders of adrenal gland

150

481

3.31

37.72

1.5

1.6

1.26

1.19

g/l

1.78

138

454

Chronic diseases of tonsils and adenoids

1648

7358

1.43

37.65

1.7

1.18

1.17

g/l

0.16

1570

7036

Herpesviral [herpes simplex] infections

293

1309

2.31

37.61

2.0

1.6

1.17

1.19

g/l

0.30

275

1231

Other retinal disorders

1185

6168

1.51

37.51

1.7

1.6

1.16

1.18

g/l

1.01

1132

5838

Other symptoms and signs involving the circulatory and respiratory systems

162

545

3.09

37.11

2.0

1.5

1.20

1.18

g/l

0.29

149

516

Psychiatric diseases

2054

7505

1.38

37.03

1.7

1.20

1.17

g/l

3.30

1962

7143

Other cataract

826

3858

1.64

36.97

2.0

1.5

1.18

1.19

g/l

0.13

786

3654

Exclusions for E4_PCOS_BROAD

414

2120

2.00

36.93

1.7

1.22

1.17

g/l

2.00

395

2018

Pneumonia due to other infectious organisms, not elsewhere classified

107

280

4.07

36.69

2.0

1.4

1.17

1.18

g/l

0.17

102

264

Recurrent aphthous stomatitis , including avohilmo

344

1654

2.14

36.67

2.0

1.7

1.17

1.18

g/l

0.24

330

1567

Other dermatomyositis

12.07

36.49

1.5

1.1

1.12

1.25

g/l

1.54

Other epidermal thickening

125

366

3.60

36.23

1.9

1.4

1.16

1.20

g/l

0.83

118

344

All influenza (not pneumonia)

313

1457

2.20

36.07

1.8

1.6

1.16

1.19

g/l

0.74

291

1384

Diabetes mellitus

2137

9261

1.36

35.96

1.5

1.8

1.27

1.15

g/l

54.71

2037

8816

Viral warts

248

1052

2.44

35.95

2.6

1.6

1.13

1.17

g/l

1.54

241

991

Diabetes, varying definitions

2125

9234

1.36

35.85

1.5

1.8

1.27

1.15

g/l

55.02

2025

8790

IBD patients in KELA-register

514

2853

1.84

35.68

1.5

1.7

1.18

g/l

0.01

489

2726

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

119

342

3.71

35.65

2.2

1.5

1.16

1.21

g/l

0.82

113

321

Suggestive for eosinophilic asthma

218

877

2.57

35.47

1.5

1.6

1.20

1.17

g/l

0.88

211

830

Trochanteric bursitis

302

1398

2.22

35.39

1.7

1.6

1.20

1.19

g/l

0.54

284

1320

Ulcerative colitis, NAS

334

1615

2.13

35.06

1.5

1.7

1.17

1.19

g/l

0.53

316

1532

Haemorrhage, not elsewhere classified

222

4.34

34.97

2.1

1.4

1.16

1.18

g/l

0.29

209

Other disorders of eye and adnexa

347

1705

2.09

34.94

1.8

1.20

1.18

g/l

0.57

327

1614

Other diseases of anus and rectum

570

3270

1.77

34.91

1.8

1.5

1.16

1.18

g/l

1.24

541

3089

Lichen simplex chronicus and prurigo

155

528

3.06

34.86

1.5

1.6

1.22

1.18

g/l

0.86

146

502

Obesity, other/unspecified

772

4814

1.63

34.85

1.6

1.8

1.34

1.16

g/l

50.11

734

4600

Etanercept

187

712

2.75

34.27

1.6

1.7

1.19

g/l

0.05

174

668

Protozoal diseases

106

291

3.93

34.17

2.0

1.4

1.13

1.16

g/l

0.47

101

276

Ocular pain

224

931

2.50

34.11

1.8

1.21

1.18

g/l

0.93

210

879

Localized swelling, mass and lump of skin and subcutaneous tissue

630

3751

1.71

34.09

1.8

1.7

1.16

1.18

g/l

0.85

604

3565

Misadventures to patients during surgical and medical care

327

1586

2.12

34.07

1.7

1.6

1.20

1.18

g/l

0.62

308

1502

Missing teeth due to accident, extraction or parodontitis

1123

7186

1.49

33.85

1.7

1.6

1.18

g/l

0.32

1062

6831

Adjustment and management of implanted device

340

1674

2.07

33.80

1.5

1.17

g/l

0.02

317

1570

Sequelae of cerebrovascular disease

626

3195

1.71

33.76

1.9

1.5

1.18

1.16

g/l

0.55

593

3021

Other and unspecified erythematous conditions

106

293

3.87

33.72

2.0

1.5

1.23

1.18

g/l

0.98

101

276

COPD, hospital admission 2, with asthma infections

553

2714

1.77

33.56

1.5

1.18

1.17

g/l

0.08

515

2567

Other and unspecified disorders of skin and subcutaneous tissue

156

545

2.98

33.55

2.2

1.5

1.11

1.19

g/l

2.24

149

518

Other shoulder lesions

218

902

2.49

33.33

1.7

1.6

1.22

1.18

g/l

1.00

206

853

Nonorganic sleeping disorders, excluding more controls

427

2286

1.91

33.31

1.9

1.7

1.18

1.17

g/l

0.33

407

2184

Seborrhoeic keratosis

409

2161

1.93

33.19

1.9

1.5

1.17

1.18

g/l

0.69

382

2041

Cardiomyopathies, Primary/intrinsic

226

951

2.44

33.15

1.4

1.18

1.20

g/l

0.32

208

893

Inflammatory bowel disease, strict (require KELA)

514

2918

1.80

33.13

1.5

1.7

1.18

g/l

0.03

489

2786

Falls/tendency to fall

2311

8750

1.33

33.09

1.8

1.7

1.19

1.17

g/l

1.94

2204

8338

External causes of morbidity and mortality

1383

4816

1.45

33.00

1.7

1.18

1.16

g/l

1.31

1307

4624

Cardiomyopathy, other and unspecified

165

599

2.85

32.91

1.6

1.4

1.14

1.21

g/l

1.58

155

561

Amyloidosis

181

4.72

32.48

1.6

1.4

1.15

1.12

g/l

0.36

175

Allergic contact dermatitis

304

1462

2.13

32.37

1.5

1.7

1.20

1.19

g/l

0.26

287

1387

Crohn's disease NAS

179

686

2.72

32.36

1.7

1.21

1.18

g/l

0.46

171

648

Other diseases of intestine

292

1383

2.16

32.31

1.6

1.5

1.19

g/l

0.11

279

1306

Nonischemic cardiomyopathy

204

830

2.53

32.27

1.8

1.5

1.15

1.17

g/l

0.56

192

782

Viral and other specified intestinal infections

597

3428

1.71

32.14

1.8

1.17

g/l

0.07

567

3280

Irregular menses

1113

5997

1.49

32.14

2.1

1.8

1.18

1.17

g/l

0.46

1062

5709

Multiple myeloma, including Hilmo

116

350

3.48

32.09

1.7

1.5

1.13

1.16

g/l

0.46

109

330

Other inflammation of eyelid

305

1479

2.12

31.84

2.1

1.5

1.16

1.19

g/l

1.14

289

1393

Ulcerative colitis

523

3018

1.77

31.83

1.6

1.7

1.20

1.18

g/l

0.41

492

2880

Gastroduodenal ulcer

452

2488

1.84

31.83

1.7

1.5

1.17

g/l

0.03

422

2359

Cardiomyopathy (excluding other)

231

1002

2.36

31.65

1.4

1.18

1.20

g/l

0.33

213

941

Hypotension

304

1473

2.11

31.59

1.6

1.4

1.17

1.16

g/l

0.11

283

1383

Valvular operations

247

1103

2.29

31.55

1.7

1.4

1.14

1.19

g/l

1.39

234

1034

Other inflammatory liver diseases

168

633

2.76

31.39

2.1

1.6

1.18

1.19

g/l

0.11

157

600

Ovarian cyst

823

3013

1.60

31.39

1.8

1.18

g/l

0.04

788

2858

Injury, poisoning and certain other consequences of external causes

1139

3861

1.49

31.29

1.8

1.7

1.18

1.16

g/l

0.54

1084

3694

Actinic keratosis

628

3526

1.67

31.26

1.6

1.5

1.15

1.17

g/l

1.10

588

3321

Angina pectoris

958

4218

1.53

31.26

1.6

1.5

1.19

1.18

g/l

0.44

908

4006

Type 2 diabetes

1990

8718

1.34

31.15

1.5

1.7

1.28

1.15

g/l

63.15

1897

8300

Myocardial infarction, without ST-elevation

655

3661

1.65

31.06

1.6

1.5

1.18

1.17

g/l

0.62

623

3452

DVT of lower extremities

374

1963

1.95

31.05

1.9

1.5

1.17

1.19

g/l

0.46

357

1851

Melanocytic naevi

630

3852

1.66

30.90

2.0

1.7

1.15

1.18

g/l

1.88

602

3673

Other symptoms and signs involving the digestive system and abdomen

347

1781

1.99

30.78

1.8

1.6

1.19

1.18

g/l

0.29

327

1700

AV-block

285

1181

2.15

30.72

1.4

1.17

1.19

g/l

0.49

262

1104

Other CVD

354

1830

1.97

30.68

1.6

1.5

1.17

g/l

0.10

330

1719

Other disorders of bone

430

2374

1.85

30.51

1.7

1.20

1.19

g/l

0.34

404

2257

Psoriasis

570

3407

1.70

30.51

1.6

1.7

1.25

1.18

g/l

6.14

547

3235

Keratitis

712

4503

1.60

30.31

1.9

1.7

1.18

g/l

0.04

673

4284

Non-Hodgkin lymphoma, all, including Hilmo

266

1249

2.18

30.18

1.7

1.5

1.13

1.18

g/l

1.60

255

1177

Skin changes due to chronic exposure to nonionizing radiation

643

3651

1.65

30.15

1.6

1.5

1.15

1.17

g/l

1.08

600

3442

Other metabolic disorders

312

1559

2.05

30.04

1.6

1.8

1.22

1.18

g/l

1.60

292

1480

Seborrhoeic dermatitis

199

829

2.47

30.02

1.9

1.6

1.15

1.17

g/l

0.36

192

784

Myocardial infarction, strict

744

3353

1.60

29.75

1.6

1.5

1.19

1.18

g/l

0.73

704

3172

Other enthesopathy of foot (+metatarsalgia)

226

1000

2.32

29.72

2.0

1.6

1.20

1.19

g/l

0.28

217

946

Non-invasive ventilation

410

1992

1.86

29.70

1.5

1.6

1.23

1.14

g/l

6.83

361

1908

Hyperparathyroidism

352

1816

1.96

29.69

1.9

1.5

1.15

1.19

g/l

1.51

326

1710

Other specified/unspecified inflammatory spondylopathies

134

462

3.03

29.63

1.9

1.8

1.20

1.18

g/l

0.32

129

433

Chronic laryngitis and laryngotracheitis

295

1452

2.08

29.56

1.8

1.6

1.15

1.18

g/l

0.82

278

1382

Injuries to the ankle and foot

1476

9577

1.38

29.51

1.9

1.7

1.19

1.17

g/l

1.41

1413

9118

Multiple myeloma and malignant plasma cell neoplasms

119

386

3.23

29.30

1.8

1.4

1.12

1.16

g/l

0.73

111

371

Systemic disorders of connective tissue in diseases classified elsewhere

11.93

29.12

1.5

1.2

1.21

1.17

g/l

0.25

Dermatophytosis

277

1342

2.12

29.03

1.9

1.5

1.19

1.18

g/l

0.14

267

1270

Other specified/unspecified soft tissue disorders

120

393

3.18

28.97

1.9

1.6

1.26

1.19

g/l

1.36

115

370

Pacemaker

534

3041

1.71

28.92

1.4

1.5

1.15

1.16

g/l

0.46

497

2865

Drug-induced adrenocortical insufficiency

213

4.25

28.91

1.7

1.5

1.29

1.19

g/l

1.84

206

Vascular disorders of the intestines

141

505

2.88

28.89

1.9

1.5

1.11

1.17

g/l

1.28

132

472

Episcleritis

155

587

2.77

28.86

2.1

1.7

1.25

1.19

g/l

1.62

147

554

Injuries to the thorax

830

5490

1.53

28.75

1.7

1.6

1.19

1.18

g/l

0.31

787

5207

Radiculopathy

307

1547

2.03

28.72

1.6

1.18

g/l

0.01

292

1460

Type 1 diabetes

519

3073

1.71

28.63

1.6

1.7

1.14

1.15

g/l

0.13

490

2928

Artrosis, including avohilmo

1672

6762

1.36

28.55

1.6

1.7

1.21

1.17

g/l

6.55

1597

6419

Other and unspecified disorders of white blood cells

118

388

3.21

28.51

2.1

1.5

1.10

1.20

g/l

2.54

109

366

Diseases of pulp and periapical tissues, including avohilmo

2162

8580

1.31

28.47

1.7

1.19

1.16

g/l

4.97

2063

8159

Gastric ulcer

315

1606

2.00

28.46

1.7

1.5

1.17

1.18

g/l

0.15

295

1519

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

122

412

3.14

28.24

1.7

1.5

1.21

1.20

g/l

0.07

106

386

Diseases of tongue

150

563

2.76

28.23

1.9

1.5

1.18

1.20

g/l

0.25

139

529

Adhesive capsulitis of shoulder

314

1605

2.00

28.22

1.5

1.20

1.18

g/l

0.42

300

1520

Special screening examination for infectious and parasitic diseases

472

1984

1.77

28.22

1.9

1.7

1.14

1.19

g/l

2.73

446

1908

Operations 2 for CAVS

466

2607

1.76

28.14

1.6

1.4

1.17

1.16

g/l

0.34

436

2447

Calcific aortic valvular stenosis, diagnosis (helper)

466

2607

1.76

28.14

1.6

1.4

1.17

1.16

g/l

0.34

436

2447

Abnormal findings on diagnostic imaging of other body structures

293

1467

2.05

28.08

1.8

1.6

1.19

g/l

0.11

276

1385

Chronic tubulo-interstitial nephritis

102

310

3.45

27.93

1.5

1.7

1.13

1.17

g/l

0.49

295

Persons encountering health services for specific procedures, not carried out

201

870

2.38

27.93

1.7

1.21

1.17

g/l

1.06

188

817

Other medical care

816

4854

1.53

27.90

1.4

1.6

1.16

1.18

g/l

0.66

781

4591

Calcific aortic valvular stenosis, operated

466

2616

1.75

27.81

1.6

1.4

1.17

1.16

g/l

0.34

436

2455

Calcific aortic valvular stenosis

466

2616

1.75

27.81

1.6

1.4

1.17

1.16

g/l

0.34

436

2455

Iron deficiency anaemia secondary to blood loss (chronic)

314

1615

1.99

27.77

1.7

1.6

1.13

1.18

g/l

1.50

296

1514

Behavioural syndromes associated with physiological disturbances and physical factors

1890

10197

1.32

27.74

1.7

1.18

g/l

0.05

1808

9698

Brachial plexus disorders

236

1096

2.22

27.73

1.5

1.8

1.22

1.19

g/l

1.02

230

1038

Calcific aortic valvular stenosis, including rheumatic fever

467

2625

1.75

27.64

1.6

1.4

1.17

1.16

g/l

0.39

437

2463

Other chronic obstructive pulmonary disease, including avohilmo

908

5072

1.50

27.60

1.5

1.17

1.18

g/l

0.33

858

4805

Metatarsalgia

209

924

2.33

27.59

1.9

1.6

1.20

1.19

g/l

0.23

200

874

COPD, hospital admissions

749

4114

1.56

27.58

1.5

1.17

1.18

g/l

0.21

705

3891

Other Crohn's disease

182

760

2.48

27.53

1.7

1.20

1.18

g/l

0.43

171

718

Viral warts

460

2674

1.75

27.42

2.3

1.7

1.14

1.18

g/l

1.66

437

2550

COPD, early/later onset

755

4147

1.55

27.40

1.5

1.17

1.18

g/l

0.18

711

3921

Acute nephritic syndrome

202

4.17

27.40

2.3

1.4

1.11

1.19

g/l

1.38

192

COPD related to multimorbidity

643

3414

1.61

27.34

1.5

1.18

1.17

g/l

0.14

602

3224

Cytomegaloviral disease

249

3.82

27.27

2.1

1.5

1.09

1.20

g/l

2.16

239

Scleritis

136

5.07

27.21

1.8

1.4

1.24

1.23

g/l

0.06

130

Other follicular disorders

186

790

2.44

27.09

1.6

1.8

1.19

1.18

g/l

0.28

179

746

Transient ischemic attack

899

4927

1.49

27.04

1.7

1.5

1.18

1.17

g/l

0.27

850

4664

Diseases of oral cavity, salivary glands and jaws

1095

3899

1.46

26.95

1.6

1.5

1.18

1.17

g/l

0.10

1029

3683

Injuries to the knee and lower leg

2418

10529

1.28

26.93

1.7

1.20

1.17

g/l

5.42

2309

10006

Infective dermatitis

224

1029

2.23

26.91

1.6

1.14

1.18

g/l

1.01

213

969

Oter anti-inflammatory and antirheumatic agents, non-steroids

390

1153

1.89

26.89

1.6

1.7

1.19

1.14

g/l

2.44

362

1091

Other and unspecified myopathies

177

738

2.47

26.73

1.3

1.4

1.17

g/l

0.01

167

698

Other/unspecified synovitis and tenosynovitis

235

1103

2.18

26.73

2.1

1.6

1.17

1.19

g/l

0.57

225

1039

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1854

8488

1.33

26.72

1.4

1.7

1.27

1.15

g/l

46.60

1762

8086

Crohn's disease of small intestine

179

753

2.47

26.65

1.7

1.8

1.18

g/l

0.02

172

714

Covid-19 suspected case

480

2845

1.72

26.65

1.9

1.8

1.19

1.17

g/l

0.49

463

2704

Diabetic maculopathy, excluding more controls

225

1040

2.22

26.64

1.4

1.6

1.19

1.15

g/l

1.00

216

981

Cerebral palsy and other paralytic syndromes

250

1205

2.13

26.62

2.0

1.6

1.23

1.18

g/l

2.11

235

1139

Sacroiliitis, not elsewhere classified

129

466

2.88

26.22

1.6

1.9

1.24

1.17

g/l

1.69

120

436

Bullous disorders

136

507

2.79

26.02

1.7

1.5

1.18

1.17

g/l

0.07

131

479

Endometriosis

766

2933

1.55

26.02

1.7

1.8

1.19

1.18

g/l

0.36

732

2782

Prurigo nodularis

191

4.13

25.99

1.3

1.5

1.23

1.17

g/l

0.92

183

Other diseases of oesophagus

193

846

2.34

25.99

2.2

1.5

1.16

1.19

g/l

0.79

183

803

Other/unspecified reactive arthropathies

167

690

2.51

25.91

2.6

1.6

1.20

1.19

g/l

0.06

159

653

COPD, hospital admissions 3, with asthma pneumonia sepsis

441

2183

1.75

25.79

1.5

1.17

g/l

0.08

408

2066

Congenital malformations, deformations and chromosomal abnormalities

1335

9043

1.37

25.76

1.7

1.8

1.17

1.18

g/l

0.58

1279

8609

Benign neoplasm of other and ill-defined parts of digestive system

360

1987

1.85

25.71

1.6

1.21

1.18

g/l

0.83

343

1869

Fenamates

297

1020

2.01

25.48

1.7

1.9

1.21

1.13

g/l

3.42

283

968

Erythema nodosum

269

3.54

25.48

1.8

1.6

1.21

1.20

g/l

0.15

252

Postprocedural disorders of nervous system

197

883

2.31

25.39

2.0

1.16

1.18

g/l

0.28

186

831

Other disorders of pigmentation

113

387

3.05

25.39

1.5

1.15

1.20

g/l

1.08

104

361

Cytomegalovirus infection, IBD co-morbidity

247

3.72

25.35

2.1

1.6

1.09

1.20

g/l

2.16

237

Corns and callosities

146

571

2.64

25.34

2.0

1.5

1.12

1.19

g/l

1.83

138

544

Dental caries, including avohilmo

1422

5336

1.37

25.16

1.6

1.19

1.17

g/l

1.67

1356

5038

Hypoparathyroidism

106

353

3.17

25.14

2.6

1.6

1.18

1.20

g/l

0.15

335

Haemorrhoids and perianal venous thrombosis

563

3516

1.62

25.07

1.5

1.17

1.18

g/l

0.46

545

3315

Cirrhosis of liver, NAS

127

467

2.83

25.01

1.3

1.5

1.08

1.17

g/l

2.04

118

447

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

281

1445

1.99

24.97

1.4

1.5

1.11

1.19

g/l

3.43

265

1369

Disorder of lipoprotein metabolism, unspecified

231

1106

2.13

24.94

1.5

1.22

1.16

g/l

2.40

220

1051

Disorders of vitreous body and globe

929

6212

1.45

24.89

1.6

1.17

1.19

g/l

0.88

871

5894

Complications of internal orthopaedic prosthetic devices, implants and grafts

398

2282

1.77

24.89

1.6

1.5

1.22

1.17

g/l

2.09

371

2143

Lichen planus

265

1338

2.03

24.89

1.6

1.5

1.19

g/l

0.05

254

1266

Hyperkinetic disorders, excluding more controls

260

1243

2.05

24.86

1.8

1.9

1.15

1.14

g/l

0.27

249

1196

Polycystic ovarian syndrome, consortium definition

1560

6927

1.35

24.86

2.0

1.8

1.19

1.17

g/l

0.79

1478

6589

Disorders of ocular muscles, binocular movement, accommodation and refraction

968

6740

1.44

24.84

1.8

1.7

1.18

1.17

g/l

0.35

911

6425

Congenital malformations, deformations and chromosomal abnormalities

1221

8487

1.38

24.80

1.7

1.8

1.17

1.18

g/l

0.41

1169

8079

Epilepsy

557

3478

1.62

24.75

2.0

1.6

1.15

g/l

0.00

523

3315

Cerebral cysts

146

579

2.62

24.72

1.6

1.7

1.12

1.18

g/l

1.47

141

550

Diseases of external ear

646

4196

1.56

24.61

1.6

1.7

1.21

1.18

g/l

2.35

614

3990

Retention of urine

566

2905

1.62

24.56

1.5

1.17

g/l

0.06

520

2746

Disorders of vitreous body

906

6082

1.46

24.54

1.6

1.17

1.19

g/l

0.84

850

5771

Emphysema

141

551

2.63

24.45

1.7

1.4

1.16

g/l

0.04

133

517

Sleep disorders

1795

9980

1.31

24.43

1.7

1.18

g/l

0.35

1713

9492

Open wound of lower leg

309

1653

1.91

24.39

2.0

1.6

1.16

1.18

g/l

0.59

299

1567

Amputation of foot

205

3.89

24.32

1.4

1.3

1.07

1.16

g/l

1.57

198

Neuralgia and neuritis, unspecified

122

446

2.84

24.25

1.5

1.7

1.20

1.18

g/l

0.45

114

416

Excessive, frequent and irregular menstruation

852

3156

1.50

24.25

2.1

1.8

1.20

1.18

g/l

1.12

810

2996

Hernia

1813

9360

1.31

24.16

1.7

1.18

g/l

0.19

1705

8924

Other bursopathies

243

1202

2.06

24.07

1.8

1.5

1.18

g/l

0.02

231

1134

Polyuria

408

2379

1.74

24.07

1.8

1.5

1.16

1.17

g/l

0.38

385

2257

Other diseases of blood and blood-forming organs

156

646

2.50

24.06

1.8

1.5

1.22

1.18

g/l

0.91

143

612

Impingement syndrome of shoulder

421

2475

1.73

24.06

1.8

1.5

1.18

g/l

0.12

403

2350

Diseases of middle ear and mastoid

1168

6938

1.39

24.00

1.8

1.17

g/l

0.06

1109

6622

Vitreous haemorrhage

204

948

2.21

23.93

1.4

1.5

1.17

1.18

g/l

0.09

190

893

Lichen ruber planus, wide definition including periferal and oral lichen planus

434

2580

1.71

23.93

1.6

1.19

1.20

g/l

0.29

413

2435

Crohn disease (strict definition, require KELA)

167

716

2.42

23.90

1.8

1.7

1.18

1.19

g/l

0.05

161

670

Abnormal involuntary movements

279

1455

1.96

23.85

1.8

1.6

1.17

1.18

g/l

0.34

263

1373

Postprocedural endocrine and metabolic disorders, not elsewhere classified

278

1449

1.97

23.83

1.6

1.8

1.22

1.18

g/l

1.60

259

1381

Nummular dermatitis

156

648

2.48

23.80

1.4

1.5

1.18

1.17

g/l

0.07

149

616

Superficial injury of lower leg

508

3149

1.64

23.72

1.6

1.7

1.21

1.18

g/l

1.95

476

2991

Personality disorders, excluding more controls

516

3211

1.63

23.63

1.7

1.8

1.20

1.17

g/l

1.56

487

3066

Diseases of pulp and periapical tissues and dental caries

1270

4736

1.38

23.62

1.6

1.19

1.16

g/l

2.33

1209

4466

Pneumonia derived septicemia

313

3.22

23.56

3.0

1.3

1.11

1.19

g/l

1.36

293

Other diseases of hard tissues of teeth

1063

3887

1.43

23.51

1.6

1.5

1.18

1.17

g/l

0.54

999

3672

Crohn disease (strict definition, require KELA, min 2 HDR)

165

709

2.41

23.51

1.7

1.18

g/l

0.02

159

663

Spirochaetal infections, other/unspecified

194

894

2.24

23.35

1.8

1.6

1.13

1.19

g/l

2.20

176

845

Deviated nasal septum

574

3669

1.58

23.34

1.6

1.20

1.18

g/l

1.26

542

3506

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

681

4532

1.52

23.25

1.7

1.20

1.18

g/l

0.63

641

4310

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

174

769

2.34

23.22

1.7

1.18

1.19

g/l

0.21

167

721

Nonalcoholic fatty liver disease

226

1108

2.10

23.15

1.7

1.29

1.19

g/l

4.58

214

1051

Other local infections of skin and subcutaneous tissue

218

1055

2.12

23.05

2.0

1.6

1.16

1.17

g/l

0.11

204

1001

Diabetes, insulin treatment (Kela reimbursement)

1942

9161

1.29

22.92

1.4

1.7

1.27

1.16

g/l

41.57

1849

8725

Viral infections of the central nervous system

183

830

2.28

22.91

2.5

1.7

1.12

1.19

g/l

2.10

173

784

Insomnia

1757

9911

1.30

22.89

1.6

1.7

1.18

g/l

0.29

1676

9431

Fracture of rib(s), sternum and thoracic spine

521

3279

1.61

22.80

1.7

1.6

1.19

1.18

g/l

0.27

496

3098

Paralytic ileus and intestinal obstruction

434

2610

1.68

22.71

1.5

1.17

1.19

g/l

0.65

408

2459

COPD-related respiratory insufficiency

206

980

2.15

22.70

1.4

1.17

1.16

g/l

0.15

188

928

Disorders of oesophagus in diseases classified elsewhere

197

3.86

22.64

2.2

1.3

1.13

1.20

g/l

1.16

188

Abnormal serum enzyme levels

482

2904

1.64

22.61

1.7

1.5

1.20

1.16

g/l

2.01

460

2761

Viral infections of the central nervous system

172

766

2.32

22.52

2.6

1.7

1.13

1.19

g/l

1.62

162

721

Trigeminal neuralgia

138

559

2.56

22.37

1.6

1.24

1.18

g/l

1.42

128

528

Persistent mood disorders

387

2273

1.73

22.31

1.7

1.22

1.18

g/l

1.71

356

2170

Spondylolisthesis/Spondylolysis

339

1918

1.80

22.29

1.7

1.6

1.17

1.19

g/l

0.60

322

1817

Problems related to lifestyle

224

1109

2.07

22.25

1.8

1.7

1.18

g/l

0.05

216

1050

Other disorders of bladder

219

1078

2.08

22.07

3.5

1.5

1.16

g/l

0.03

207

1020

Type 1 diabetes, wide definition, subgroup 1

426

2573

1.68

22.01

1.5

1.7

1.12

1.15

g/l

1.14

400

2453

Heartburn

218

1074

2.08

21.92

1.6

1.18

g/l

0.03

204

1017

Other and unspecified local infections of skin and subcutaneous tissue

205

989

2.13

21.90

2.0

1.6

1.18

1.17

g/l

0.09

191

940

Other hammer toe(s) (acquired)

274

1340

1.92

21.88

1.6

1.4

1.17

1.18

g/l

0.18

260

1266

Psoriatic arthropathies, ICD10

233

1180

2.03

21.82

1.6

1.24

1.19

g/l

1.52

224

1113

Other/unspecified enthesopathies, not elsewhere classified

168

751

2.29

21.69

1.7

1.5

1.20

1.19

g/l

0.20

163

707

Other psoriatic arthropathies

227

1143

2.04

21.62

1.6

1.24

1.19

g/l

1.69

220

1078

Ankylosing spondylitis

183

849

2.21

21.59

1.7

1.6

1.19

1.18

g/l

0.25

175

807

Substance abuse, excluding more controls

997

6131

1.40

21.48

1.6

1.7

1.19

1.17

g/l

1.95

943

5849

Other extrapyramidal and movement disorders in other diseases

441

2709

1.65

21.44

1.7

1.19

1.18

g/l

0.30

417

2552

Injuries to the abdomen, lower back, lumbar spine and pelvis

715

4832

1.48

21.34

1.9

1.6

1.15

1.18

g/l

1.28

678

4579

Arterial embolism and thrombosis

112

418

2.76

21.33

1.5

1.4

1.18

1.17

g/l

0.08

105

399

Generalized anxiety disorder

343

1974

1.77

21.33

1.6

1.8

1.15

1.16

g/l

0.18

329

1895

Other disorders of ear

1760

8989

1.29

21.32

1.7

1.17

1.18

g/l

1.05

1671

8552

Early onset COPD

396

2371

1.70

21.27

1.6

1.20

1.19

g/l

0.46

373

2252

Other and unspecified tonsillitis

655

3682

1.51

21.26

1.7

1.8

1.20

1.16

g/l

2.67

616

3524

Arthropathic psoriasis

237

1220

1.99

21.16

1.6

1.25

1.19

g/l

2.04

228

1147

Nonsuppurative otitis media

474

2562

1.62

21.03

1.8

1.17

1.16

g/l

0.29

460

2444

Dental operations

1121

4189

1.38

21.01

1.6

1.18

1.17

g/l

0.39

1057

3956

Lesion of ulnar nerve

270

1453

1.90

21.00

1.7

1.6

1.19

g/l

0.05

259

1382

Nonorganic sleeping disorders

427

2618

1.66

20.97

1.9

1.8

1.18

g/l

0.10

407

2495

Acute pancreatitis

354

2066

1.74

20.90

1.7

1.6

1.23

1.17

g/l

3.33

341

1955

Excessive attrition of teeth

1120

8303

1.36

20.90

1.8

1.7

1.16

1.18

g/l

1.74

1078

7904

Psoriasis vulgaris

357

2090

1.74

20.89

1.5

1.6

1.27

1.19

g/l

5.41

345

1975

Chronic iridocyclitis

123

490

2.61

20.74

2.0

1.6

1.17

1.19

g/l

0.23

118

462

Cluster headache, wide

353

2.92

20.73

1.8

1.6

1.21

1.16

g/l

0.85

333

Varicose veins

1095

6077

1.37

20.71

1.8

1.6

1.17

1.18

g/l

0.89

1044

5756

Gingivitis and periodontal diseases

1999

8164

1.27

20.61

1.7

1.18

1.17

g/l

0.72

1902

7756

Suppurative and unspecified otitis media

735

4493

1.47

20.60

1.8

1.18

1.16

g/l

0.67

694

4299

Melanocytic naevi of trunk

254

1352

1.92

20.53

2.1

1.7

1.15

1.18

g/l

0.77

246

1275

Unspecified fall

924

6560

1.40

20.52

1.7

1.6

1.19

1.17

g/l

0.68

871

6234

Viral and other specified intestinal infections

416

2482

1.66

20.52

1.9

1.8

1.16

1.17

g/l

0.06

395

2381

Aortic valve malfunction, age under 60 years

201

988

2.09

20.49

2.1

1.5

1.16

1.19

g/l

0.75

185

942

Cholelithiasis, broad definition with cholecystitis

1652

8655

1.29

20.45

1.7

1.25

1.16

g/l

26.53

1567

8231

Type 1 diabetes, wide definition

437

2711

1.63

20.32

1.5

1.7

1.13

1.15

g/l

1.02

410

2582

Mucosal proctocolitis

271

1477

1.87

20.31

1.5

1.7

1.20

1.18

g/l

0.25

255

1400

Post-traumatic stress disorder

204

1014

2.07

20.16

1.5

2.0

1.23

1.15

g/l

2.77

189

964

Injuries to the head

2195

10864

1.25

20.15

1.7

1.18

1.17

g/l

0.28

2089

10339

Acute suppurative otitis media

550

3362

1.55

20.09

1.9

1.17

1.16

g/l

0.36

522

3227

Intestinal malabsorption

114

445

2.66

20.06

1.5

1.6

1.16

1.19

g/l

0.54

108

420

Extrapyramidal and movement disorders

661

4508

1.48

20.02

1.6

1.18

g/l

0.04

626

4260

Vitamin deficiency, wide

116

457

2.63

20.01

2.3

1.6

1.14

1.17

g/l

0.44

107

428

Vitamin deficiency

116

457

2.63

20.01

2.3

1.6

1.14

1.17

g/l

0.44

107

428

Lichen planus, including avohilmo

360

2140

1.71

19.97

1.6

1.18

1.19

g/l

0.35

342

2020

Amyloidosis, other/unspecified

162

3.97

19.94

1.3

1.4

1.15

1.12

g/l

0.30

156

Panic disorder

317

1820

1.77

19.92

1.6

1.8

1.21

1.17

g/l

1.45

295

1742

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

201

1000

2.06

19.81

1.6

1.19

1.17

g/l

0.52

187

947

Cluster headache, strict

335

2.92

19.74

1.8

1.6

1.20

1.17

g/l

0.63

317

Tongue abnormality

137

587

2.42

19.72

2.0

1.6

1.18

g/l

0.01

128

559

Special screening examination for other diseases and disorders

197

973

2.06

19.63

1.7

1.5

1.19

1.18

g/l

0.11

186

927

Caries of enamel

1772

10107

1.27

19.61

1.8

1.7

1.17

1.18

g/l

1.00

1690

9637

Other/unspecified enthesopathies of lower limb, excluding foot

156

708

2.27

19.54

1.5

1.7

1.22

1.19

g/l

0.82

149

673

Need for other prophylactic measures

134

572

2.42

19.45

1.8

1.6

1.22

1.19

g/l

0.52

128

542

Crohn's disease of large intestine

130

548

2.46

19.44

1.7

1.19

1.18

g/l

0.17

122

517

Endometriosis of pelvic peritoneum

365

2088

1.70

19.42

1.7

1.8

1.18

g/l

0.03

347

1975

Diabetic retinopathy

616

2562

1.52

19.40

1.4

1.5

1.21

1.27

g/l

5.27

587

2433

Acute pharyngitis

295

1657

1.80

19.37

1.8

1.7

1.20

1.16

g/l

1.07

278

1587

Pain associated with micturition

239

1272

1.92

19.34

2.0

1.6

1.18

g/l

0.03

224

1202

Persons with potential health hazards related to communicable diseases

795

5602

1.42

19.25

2.1

1.8

1.17

g/l

0.16

761

5360

Left ventricular outflow tract obstruction (LVOTO), broad definition

213

1094

2.00

19.21

2.1

1.5

1.16

1.19

g/l

0.57

195

1044

Acute lymphadenitis

142

625

2.35

19.21

2.5

1.6

1.16

1.18

g/l

0.20

137

586

Vascular diseases of the intestine

276

3.08

19.01

2.0

1.5

1.12

1.18

g/l

0.70

263

Acute laryngitis and tracheitis

239

1256

1.91

18.98

1.9

1.8

1.19

1.16

g/l

0.98

225

1208

Cholelithiasis

1580

8521

1.29

18.94

1.7

1.25

1.16

g/l

26.39

1498

8098

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

740

3273

1.46

18.85

2.5

1.9

1.14

1.16

g/l

1.62

713

3114

Cervicocranial syndrome

209

1073

1.99

18.81

1.4

1.7

1.16

1.19

g/l

0.83

197

1016

Chronic pancreatitis

228

1206

1.93

18.78

1.4

1.5

1.17

1.18

g/l

0.14

214

1148

Infections with a predominantly sexual mode of transmission

640

4390

1.47

18.77

2.2

1.8

1.14

1.18

g/l

2.74

605

4207

Neuromuscular dysfunction of bladder

177

858

2.11

18.73

1.9

1.5

1.17

g/l

0.00

159

810

Decubitus ulcer and pressure area

108

424

2.62

18.67

1.6

1.4

1.22

1.17

g/l

0.80

406

Disease of hard tissues of teeth, NOS

996

3799

1.38

18.60

1.7

1.6

1.19

1.18

g/l

0.43

944

3593

Non-follicular lymphoma

174

841

2.12

18.56

1.7

1.5

1.10

1.17

g/l

1.98

167

797

Sub-endpoint used in defining T1D endpoints

530

3453

1.53

18.52

1.6

1.14

1.17

g/l

1.38

499

3287

Tonsillectomy and adenotomy

1189

6257

1.33

18.51

1.8

1.16

1.17

g/l

0.51

1133

5986

Other obstetric conditions, not elsewhere classified

752

3356

1.44

18.43

2.5

1.9

1.14

1.16

g/l

1.67

724

3191

Type 2 diabetes, definitions combined

1780

8298

1.27

18.38

1.5

1.7

1.30

1.15

g/l

74.21

1695

7901

Meningitis

119

495

2.49

18.34

2.9

1.5

1.18

1.19

g/l

0.12

109

464

Fracture of lumbar spine and pelvis

368

2247

1.66

18.24

2.0

1.5

1.14

1.18

g/l

2.48

352

2101

Other noninfective disorders of lymphatic vessels and lymph nodes

351

2.79

18.14

1.7

1.6

1.16

1.20

g/l

0.57

329

Caries of dentine, including avohilmo

1483

5875

1.30

18.09

1.7

1.19

1.16

g/l

1.98

1411

5557

Infections with a predominantly sexual mode of transmission

813

5457

1.40

18.06

2.1

1.8

1.14

1.17

g/l

2.32

767

5220

Fissure and fistula of anal and rectal regions

425

2702

1.59

17.96

1.7

1.6

1.19

g/l

0.13

404

2551

Lung cancer and mesothelioma

239

1103

1.88

17.95

1.5

1.4

1.12

1.18

g/l

1.38

224

1030

Visual field defects

164

786

2.14

17.92

2.0

1.6

1.17

g/l

0.07

151

741

Acute pancreatitis (for exclusion)

354

2156

1.67

17.90

1.7

1.6

1.23

1.18

g/l

2.21

341

2039

Inflammatory disease of uterus

321

1911

1.71

17.85

1.9

1.18

1.17

g/l

0.13

298

1821

Type 2 diabetes, strict (exclude DM1)

1785

8355

1.26

17.84

1.5

1.7

1.30

1.15

g/l

74.00

1700

7959

Suppurative and necrotic conditions of lower respiratory tract

113

466

2.50

17.71

2.2

1.4

1.10

1.18

g/l

1.36

103

442

Ganglion

378

2347

1.63

17.66

1.4

1.7

1.18

1.17

g/l

0.24

362

2237

Acetic acid derivatives and related substances

456

1492

1.60

17.65

1.5

1.8

1.18

1.14

g/l

1.91

430

1415

Disorders of vestibular function (Vertigo)

829

5935

1.39

17.45

1.6

1.19

1.18

g/l

0.52

792

5623

Atypical facial pain

121

519

2.41

17.44

1.6

1.7

1.20

1.19

g/l

0.24

113

495

Cardiodefibrillation

549

3703

1.50

17.44

1.7

1.5

1.17

1.18

g/l

0.28

527

3495

Hydronephrosis

190

969

2.00

17.43

1.4

1.6

1.20

1.17

g/l

0.47

184

911

Synovial cyst of popliteal space [Baker]

137

618

2.27

17.43

1.5

1.24

1.20

g/l

0.80

132

581

Menorrhagia

709

2745

1.45

17.42

1.9

1.7

1.19

1.18

g/l

0.54

666

2602

Other disorders of eyelid

730

4949

1.42

17.41

1.6

1.5

1.20

1.18

g/l

0.93

694

4670

KRA_PSY_EATING, excluding more controls

190

966

2.00

17.39

1.9

1.12

1.13

g/l

0.14

183

922

Cluster headache, wide,, including avohilmo

131

584

2.32

17.29

1.8

1.7

1.21

1.18

g/l

0.64

125

545

Diseases of peritoneum

197

1023

1.97

17.23

1.6

1.15

1.17

g/l

0.38

191

971

Lateral epicondylitis

243

1348

1.84

17.23

1.6

1.21

1.19

g/l

0.58

232

1284

Chorioretinal inflammation

266

3.03

17.22

1.9

1.6

1.17

1.20

g/l

0.44

252

Other and unspecified visual disturbances

207

1094

1.94

17.20

1.9

1.6

1.23

1.18

g/l

1.57

201

1035

Injuries to the hip and thigh

799

5238

1.39

17.16

1.7

1.6

1.18

1.17

g/l

0.25

761

4960

Elevated blood glucose level

161

780

2.12

17.12

1.4

1.5

1.24

1.18

g/l

1.61

153

737

Injuries to the wrist and hand

1951

10971

1.24

17.05

1.7

1.18

1.17

g/l

0.33

1850

10450

Otitis externa

425

2748

1.57

16.79

1.8

1.7

1.21

1.18

g/l

0.87

406

2609

Cluster headache, strict, including avohilmo

126

560

2.33

16.78

1.8

1.7

1.21

1.18

g/l

0.52

120

521

Speech therapy

476

3154

1.53

16.78

1.9

1.6

1.18

1.19

g/l

0.30

451

2979

Diabetes medication

2002

9656

1.24

16.75

1.4

1.8

1.28

1.15

g/l

56.28

1902

9194

Other and unspecified diseases of blood and blood-forming organs

244

3.11

16.70

2.3

1.6

1.25

1.16

g/l

1.32

232

Benign neoplasm: Colon, unspecified

414

2669

1.57

16.54

1.7

1.5

1.18

g/l

0.08

392

2521

Disorders of optic nerve and visual pathways

206

1109

1.90

16.23

1.9

1.7

1.17

1.18

g/l

0.22

197

1042

Other and unspecified nerve root and plexus disorders, also in other diseases

364

2291

1.61

16.18

1.6

1.21

1.19

g/l

0.66

338

2182

Hereditary angioödema type 1

41.27

16.11

3.0

1.3

1.16

1.20

g/l

—

Other diseases of pancreas

157

773

2.08

16.04

1.6

1.5

1.17

g/l

0.03

146

729

Type 2 diabetes, definitions combined, including avohilmo

1779

8364

1.25

15.94

1.5

1.7

1.31

1.15

g/l

78.58

1696

7966

Acne

224

1242

1.84

15.93

2.1

1.9

1.11

1.16

g/l

1.92

208

1189

Otitis externa, unspecified

228

1276

1.82

15.82

1.7

1.20

1.18

g/l

0.49

217

1209

Diabetic retinopathy, strict definition

318

1714

1.67

15.81

1.3

1.5

1.17

1.28

g/l

6.94

303

1632

Unspecified/other endometriosis

215

1183

1.86

15.80

1.6

1.9

1.22

1.16

g/l

2.47

202

1119

Disorders of refraction and accommodation

527

3598

1.48

15.74

1.9

1.8

1.17

1.18

g/l

0.14

498

3436

Dental pulpitis, including avohilmo

1804

9509

1.24

15.63

1.7

1.8

1.22

1.17

g/l

8.36

1726

9066

Retinal detachments and breaks

578

4036

1.45

15.60

1.5

1.16

1.18

g/l

0.82

550

3807

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

404

2.52

15.53

2.0

1.5

1.14

1.18

g/l

0.54

384

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

362

2301

1.60

15.53

2.0

1.9

1.17

g/l

0.09

350

2197

Other sleep disorders

205

1117

1.87

15.48

1.9

1.6

1.20

1.16

g/l

1.47

193

1060

FESS (DNB20)

253

1469

1.76

15.48

1.7

1.20

1.19

g/l

0.45

243

1390

Carrier of infectious disease

272

2.91

15.46

2.3

1.6

1.19

1.17

g/l

0.16

256

Procreative management

657

3904

1.42

15.46

1.8

1.7

1.17

1.19

g/l

0.84

615

3740

Ethmoidectomy

259

1521

1.74

15.21

1.7

1.21

1.19

g/l

0.47

249

1439

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

343

2099

1.61

15.12

1.7

1.16

1.18

g/l

0.63

333

1996

Supplementary factors related to causes of morbidity and mortality classified elsewhere

567

3970

1.44

15.12

1.9

1.7

1.16

1.18

g/l

0.74

538

3763

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

159

805

2.03

15.09

1.8

1.7

1.19

1.17

g/l

0.37

152

767

Aortic aneurysm

316

1915

1.64

15.06

1.5

1.16

g/l

0.04

298

1814

Restless leg syndrome

260

1534

1.73

15.02

1.7

1.6

1.20

1.19

g/l

0.29

250

1450

Unstable angina pectoris

523

2828

1.47

15.01

1.7

1.5

1.20

1.17

g/l

1.58

486

2669

Disorders of continuity of bone

199

1089

1.87

14.91

2.1

1.6

1.17

1.18

g/l

0.36

191

1026

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

166

843

1.99

14.90

2.5

1.7

1.14

1.16

g/l

0.44

159

796

Other female pelvic inflammatory diseases

326

2043

1.62

14.88

1.7

1.8

1.17

1.19

g/l

0.67

305

1937

Other or unspecified ileus, impaction or obstruction

286

1731

1.67

14.85

1.4

1.5

1.19

1.18

g/l

0.29

270

1629

Hypopituitarism

150

748

2.06

14.84

1.8

1.5

1.22

1.19

g/l

0.37

144

714

Injuries to the neck

432

2882

1.52

14.82

1.6

1.7

1.21

1.17

g/l

1.51

415

2745

Postmenopausal osteoporosis with pathological fracture

118

538

2.26

14.76

2.0

1.5

1.11

1.20

g/l

2.14

111

507

Propionic acid derivatives

491

1648

1.51

14.73

1.5

1.8

1.19

1.13

g/l

3.93

467

1566

Intracranial injury

1035

7546

1.31

14.71

1.8

1.7

1.18

1.17

g/l

0.40

978

7182

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

327

1991

1.62

14.66

1.7

1.16

1.18

g/l

0.66

318

1891

Delirium, not induced by alcohol and other psychoactive substances

185

992

1.89

14.60

1.9

1.4

1.13

1.15

g/l

0.35

176

930

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

424

2507

1.52

14.59

1.8

1.9

1.17

1.16

g/l

0.49

406

2401

Retinal vascular occlusion

190

1031

1.88

14.56

1.4

1.5

1.16

1.17

g/l

0.11

181

962

Retinal vascular disorders

191

1038

1.87

14.55

1.4

1.5

1.16

1.17

g/l

0.13

181

969

Dilated cardiomyopathy

197

1083

1.85

14.51

1.4

1.5

1.19

1.18

g/l

0.21

182

1025

Oesophageal varices

338

2.60

14.50

1.4

1.5

1.04

1.17

g/l

2.54

319

Invasive ventilation

139

681

2.09

14.45

1.7

1.4

1.19

1.18

g/l

0.16

124

646

Golimumab

346

2.58

14.37

1.6

1.7

1.20

g/l

0.10

327

Spontaneous rupture of synovium and tendon

140

688

2.08

14.37

1.7

1.5

1.21

1.20

g/l

0.15

134

646

Diabetic neuropathy

206

1147

1.83

14.35

1.3

1.4

1.21

1.25

g/l

1.01

196

1087

Superficial injury of head

418

2787

1.52

14.35

1.7

1.18

g/l

0.01

402

2636

COPD, hospital admissions 1, only main diagnosis

509

3008

1.46

14.31

1.5

1.16

1.17

g/l

0.23

482

2840

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

731

5371

1.37

14.25

1.9

1.8

1.21

1.18

g/l

2.99

706

5139

Anti-inflammatory and antirheumatic products, non-steroids

488

1648

1.50

14.23

1.5

1.8

1.19

1.13

g/l

2.96

463

1566

Chondrocostal junction syndrome [Tietze]

378

2.50

14.21

1.6

1.21

1.19

g/l

0.29

358

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

509

3520

1.46

14.20

1.7

1.8

1.19

1.16

g/l

1.12

471

3361

Scoliosis

171

906

1.93

14.18

1.6

1.8

1.19

1.17

g/l

0.24

159

864

Diseases of inner ear

935

6919

1.32

14.14

1.6

1.19

1.18

g/l

0.54

892

6561

Benign neoplasm: Ascending colon

236

1381

1.74

14.06

1.5

1.20

1.18

g/l

0.41

225

1300

Amenorrhoea

165

868

1.95

14.04

2.2

1.9

1.13

1.16

g/l

0.77

158

824

Benign neoplasm: Transverse colon

186

1016

1.87

14.03

1.6

1.5

1.19

1.18

g/l

0.16

175

959

Dermatophytosis

1092

8531

1.29

14.03

1.8

1.6

1.18

g/l

0.02

1044

8132

Other disorders of conjunctiva

245

1455

1.71

13.82

1.8

1.6

1.17

1.18

g/l

0.25

233

1372

Injuries to the shoulder and upper arm

1501

9797

1.24

13.79

1.7

1.6

1.17

1.18

g/l

0.30

1425

9324

Multiple myeloma

210

3.03

13.78

1.6

1.5

1.15

g/l

0.07

199

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

210

3.03

13.78

1.6

1.5

1.15

g/l

0.07

199

Ascites

132

647

2.09

13.70

2.0

1.5

1.08

1.19

g/l

2.75

122

615

Cholecystectomy

1284

8838

1.26

13.68

1.7

1.27

1.17

g/l

27.40

1217

8402

Autoimmune hyperthyroidism

101

445

2.32

13.67

1.6

1.2

1.16

1.23

g/l

1.44

420

Secondary and unspecified malignant neoplasm of lymph nodes

147

750

2.00

13.65

1.4

1.5

1.20

1.18

g/l

0.33

142

704

Fibroblastic disorders

349

2264

1.56

13.62

1.6

1.5

1.19

1.17

g/l

0.82

332

2134

Ankylosing spondylitis, ICD10

177

962

1.88

13.61

1.6

1.20

1.18

g/l

0.32

169

912

Open wound of ankle and foot

192

1069

1.83

13.61

1.7

1.6

1.16

1.18

g/l

0.26

179

1008

Chondropathies

294

1840

1.62

13.52

1.8

1.21

1.18

g/l

0.63

273

1747

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

309

1957

1.60

13.50

1.5

1.7

1.18

g/l

0.04

291

1857

Bacterial, viral and other infectious agents

180

986

1.86

13.49

1.7

1.15

1.19

g/l

1.03

174

932

Conductive and sensorineural hearing loss

1355

7323

1.26

13.48

1.6

1.17

1.18

g/l

0.83

1286

6959

Dystonia

121

579

2.15

13.48

1.4

1.7

1.14

1.18

g/l

0.84

116

549

Pyothorax

363

2.47

13.43

2.4

1.4

1.09

1.17

g/l

1.29

350

Dislocation, sprain and strain of joints and ligaments at neck level

301

1898

1.61

13.42

1.5

1.8

1.23

1.17

g/l

2.69

290

1804

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

535

3792

1.43

13.41

1.7

1.18

g/l

0.01

506

3630

Ulcerative colitis (strict definition, require KELA)

317

2024

1.59

13.38

1.5

1.7

1.18

g/l

0.01

299

1922

Benign neoplasm: Stomach

179

982

1.86

13.36

1.6

1.5

1.21

1.19

g/l

0.42

170

935

Corneal ulcer

335

2167

1.57

13.34

1.7

1.19

1.18

g/l

0.21

321

2059

Childhood allergy (age < 16)

302

1562

1.62

13.31

1.8

2.0

1.14

1.15

g/l

0.16

288

1504

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

338

2194

1.56

13.26

1.5

1.7

1.18

g/l

0.04

320

2087

Degeneration of macula and posterior pole

702

4124

1.36

13.25

1.8

1.5

1.15

1.18

g/l

2.00

663

3876

Trigger finger

237

1411

1.70

13.23

1.6

1.19

g/l

0.03

231

1339

Abnormal blood-pressure reading, without diagnosis

396

2.39

13.22

1.9

1.6

1.20

1.17

g/l

0.36

375

Nasal polyp

312

1989

1.59

13.22

1.5

1.6

1.20

1.17

g/l

1.14

299

1890

Anogenital herpesviral [herpes simplex] infection

146

754

1.99

13.18

2.4

2.0

1.14

1.17

g/l

0.49

139

711

Type of accident

520

3681

1.43

13.14

1.9

1.7

1.16

1.18

g/l

0.94

493

3495

Other contact dermatitis

148

768

1.97

13.09

1.8

1.7

1.17

1.19

g/l

0.22

141

723

Viral meningitis

381

2.42

13.04

3.0

1.6

1.15

1.19

g/l

0.66

358

Insulin, fast-acting (human)

265

1633

1.65

12.98

1.5

1.7

1.12

1.17

g/l

2.47

251

1548

Transport accidents

828

5416

1.32

12.94

1.7

1.19

1.17

g/l

1.70

793

5182

Mental and behavioural disorders due to psychoactive substance use

1032

7495

1.28

12.93

1.6

1.19

1.17

g/l

1.29

977

7166

Alopecia areata

281

2.68

12.90

1.7

1.6

1.13

1.20

g/l

1.42

266

Substance abuse

997

7316

1.29

12.89

1.6

1.19

1.17

g/l

1.21

943

6993

conjunctival haemorrhage

135

683

2.02

12.88

1.8

1.5

1.16

1.17

g/l

0.17

128

653

Thyrotoxicosis

465

3242

1.45

12.83

1.7

1.18

g/l

0.13

432

3067

Tobacco use

115

553

2.14

12.68

1.7

1.6

1.18

1.19

g/l

0.13

110

519

Faecal incontinence

162

876

1.89

12.66

2.1

1.6

1.13

1.18

g/l

1.43

149

832

Any death

1000

5583

1.29

12.66

1.5

1.6

1.14

1.19

g/l

5.14

938

5306

Phobic anxiety disorders

264

1635

1.64

12.62

1.6

1.8

1.21

1.17

g/l

1.66

254

1564

Demyelinating diseases of the central nervous system

186

1053

1.81

12.58

1.8

1.9

1.18

g/l

0.02

179

991

Disturbance of activity and attention

253

1523

1.66

12.57

1.8

1.15

g/l

0.09

243

1455

Speech disturbances, not elsewhere classified

150

794

1.93

12.52

1.8

1.5

1.19

1.17

g/l

0.44

138

751

Benign neoplasm: Sigmoid colon

307

1977

1.57

12.50

1.7

1.5

1.18

g/l

0.06

293

1865

Pneumonia due to Streptococcus pneumoniae

332

2.48

12.49

1.7

1.4

1.16

1.19

g/l

0.34

313

Otitis media, unspecified

224

1228

1.71

12.42

1.7

1.8

1.16

g/l

0.06

212

1175

Benign neoplasm of other and unspecified endocrine glands

243

1484

1.67

12.41

1.4

1.6

1.23

1.19

g/l

1.34

223

1400

Other diseases of stomach and duodenum

117

571

2.10

12.35

1.9

1.4

1.15

1.20

g/l

0.86

112

540

Extreme obesity with alveolar hypoventilation

385

2.36

12.28

1.4

1.6

1.30

1.17

g/l

3.19

364

Glucagon-like peptide-1 (GLP-1) analogues

512

3663

1.41

12.23

1.3

1.7

1.38

1.16

g/l

47.66

488

3496

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

512

3663

1.41

12.23

1.3

1.7

1.38

1.16

g/l

47.66

488

3496

Other ulcerative colitis

121

601

2.07

12.22

1.5

1.6

1.19

g/l

0.11

109

567

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

15.42

12.21

1.5

1.2

1.23

1.15

g/l

0.35

Hypersplenism

6.57

12.14

2.2

1.5

1.08

1.15

g/l

0.43

Sensorineural hearing loss

1257

6864

1.25

12.12

1.6

1.17

1.18

g/l

0.78

1190

6517

Unspecified misadventure during surgical and medical care

111

536

2.13

12.11

1.5

1.20

1.19

g/l

0.23

102

508

Benign paroxysmal vertigo

493

3510

1.42

12.11

1.7

1.6

1.19

1.18

g/l

0.26

472

3310

Congenital malformations of the urinary system

124

624

2.04

12.10

1.6

1.14

1.19

g/l

1.11

124

589

Other and unspecified disorders of vitreous body

692

5127

1.34

12.08

1.6

1.17

1.19

g/l

1.08

650

4869

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

569

4102

1.39

12.08

2.0

1.9

1.16

g/l

0.01

542

3923

Barrett oesophagus

420

2.28

12.00

1.8

1.4

1.18

1.20

g/l

0.13

398

Intestinal stricture

487

3464

1.42

12.00

1.6

1.16

1.18

g/l

0.89

455

3270

Arthropathy in ulcerative colitis

147

3.35

11.99

2.2

1.3

1.16

1.19

g/l

0.26

141

Lesion of lateral popliteal nerve

433

2.25

11.98

1.6

1.5

1.16

1.19

g/l

0.36

409

Arthropod-borne viral fevers and viral haemorrhagic fevers

320

2101

1.54

11.95

1.7

1.17

1.19

g/l

0.56

304

1985

Vitamin B12 deficiency anaemia

163

901

1.84

11.86

1.7

1.5

1.15

1.17

g/l

0.43

153

850

Plantar fascial fibromatosis

169

946

1.82

11.83

1.8

1.6

1.24

1.19

g/l

1.61

159

894

Atrophic disorders of skin

251

1564

1.63

11.81

1.8

1.6

1.22

1.20

g/l

0.40

241

1478

Thoracic aortic aneurysm

210

1251

1.70

11.77

1.5

1.15

1.17

g/l

0.35

196

1190

Personality disorders

516

3723

1.40

11.75

1.7

1.8

1.20

1.18

g/l

1.08

487

3574

Hypercalcemia

399

2.30

11.74

1.8

1.5

1.15

1.18

g/l

0.36

377

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

924

6291

1.29

11.73

2.0

1.8

1.22

1.17

g/l

5.33

888

5982

Left bundle-branch block

108

521

2.11

11.72

1.6

1.5

1.15

1.19

g/l

0.69

485

Appendectomy

1220

9442

1.24

11.68

1.7

1.19

1.18

g/l

0.81

1160

9000

Mononeuritis multiplex

13.45

11.66

1.9

1.6

1.08

1.24

g/l

0.94

Acne vulgaris

169

951

1.81

11.66

2.0

1.9

1.13

1.17

g/l

0.67

158

907

Fracture of foot, except ankle

443

3121

1.44

11.59

1.9

1.6

1.17

1.18

g/l

0.45

424

2977

Arthropathy in hypersensitivity reactions classified elsewhere

18.15

11.54

1.5

1.1

1.26

1.25

g/l

0.06

Other disorders of nervous system

125

642

1.99

11.50

1.4

1.5

1.19

1.18

g/l

0.08

117

610

Lung diseases due to external agents

204

1214

1.70

11.47

1.7

1.5

1.21

1.15

g/l

1.77

195

1148

Oral lichen planus, including avohilmo , including avohilmo

134

707

1.94

11.43

1.7

1.18

1.19

g/l

0.14

128

667

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Complement C3 [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS